furosemide has been researched along with Cirrhosis, Liver in 272 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Patients without hyperkalemia were administrated 100 mg of spironolactone/day." | 9.22 | High Dose Oral Furosemide with Salt Ingestion in the Treatment of Refractory Ascites of Liver Cirrhosis. ( Demir, M; Dogan, O; Ozer, B; Parlakgumus, A; Serin, E; Yakar, T, 2016) |
| "To compare the safety and efficacy of intravenous high-dose furosemide + hypertonic saline solutions (HSS) with repeated paracentesis in patients with cirrhosis and refractory ascites." | 9.14 | Clinical Trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites. ( Cammà, C; Craxì, A; Di Raimondo, D; Di Sciacca, R; Licata, A; Licata, G; Parrinello, G; Paterna, S; Pinto, A; Tuttolomondo, A, 2009) |
| "Satavaptan treatment was associated with a decrease in ascites (mean change in body weight was -0." | 9.14 | Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia--a randomized, double-blind, placebo-controlled study. ( Bruha, R; Dudley, F; Ginès, P; Terg, R; Watson, H; Wong, F; Zarski, JP, 2010) |
| "Tolvaptan was orally administrated at titrated doses of 15, 30, and 60 mg once daily after breakfast for 3 days at each dose to 18 liver cirrhosis patients with persistent ascites and/or lower limb edema despite receiving oral furosemide at 40 mg/day or higher." | 9.14 | A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis. ( Chayama, K; Kaneko, A; Kato, M; Murawaki, Y; Okada, M; Okita, K; Ono, N; Sakaida, I; Sata, M; Yoshihara, H; Yoshihara, N, 2010) |
| "To conduct a randomized, double-blind, placebo-controlled, cross-over study to test the hypothesis that midodrine significantly increases natriuretic response of IV furosemide in non-azotemic cirrhotics with ascites." | 9.14 | The effects of midodrine on the natriuretic response to furosemide in cirrhotics with ascites. ( Chalasani, N; Hamman, M; Jones, D; Kahi, C; Kwo, PY; Misra, VL; Vuppalanchi, R, 2010) |
| "To evaluate the changes in renal functional mass as reflected by DMSA uptake after single injection of intravenous furosemide in patients with compensated liver cirrhosis." | 9.12 | The changes in renal function after a single dose of intravenous furosemide in patients with compensated liver cirrhosis. ( Assy, N; Gorenberg, M; Hussein, O; Kayal, M; Mejirisky, Y; Schlesinger, S, 2006) |
| " This investigation consists of a double-blind, randomized, placebo-controlled trial aimed at comparing the effects of the selective COX-2 inhibitor celecoxib (200 mg every 12 hours for a total of 5 doses) on platelet and renal function and the renal response to furosemide (40 mg intravenously) with those of naproxen (500 mg every 12 hours for a total of 5 doses) and placebo in 28 patients with cirrhosis and ascites." | 9.11 | Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites. ( Arroyo, V; Clària, J; Escolar, G; Ginès, P; Jiménez, W; Kent, JD; López-Parra, M; Ruiz-Del-Arbol, L; Vucelic, B, 2005) |
| "The most rational treatment of moderate ascites is spironolactone alone or in combination with furosemide." | 9.10 | Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety. ( Cabré, E; Durández, R; Gassull, MA; Granada, ML; Jiménez, JA; Morillas, RM; Pardo, A; Planas, R; Quintero, E; Santos, J, 2003) |
| "These results show that torsemide is as effective and safe as frusemide for long-term treatment of cirrhotic patients with ascites." | 9.09 | Long-term efficacy of torsemide compared with frusemide in cirrhotic patients with ascites. ( Abecasis, R; Cobas, S; Guevara, M; Miguez, C; Terg, R, 2001) |
| "To evaluate the pharmacokinetics and pharmacodynamics of furosemide and torasemide in patients with cirrhosis and diuretic resistant ascites." | 9.08 | Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites. ( Bernareggi, A; Buzzelli, G; Carloni, V; Chibbaro, G; Cotrozzi, G; Foschi, M; Gentilini, P; La Villa, G; Laffi, G; Marra, F; Melani, L; Quartini, M; Simoni, A; Tommasi, AC, 1996) |
| "Twenty patients with cirrhosis and ascites were randomly divided in two groups to receive 20 mg/die of the new-loop-diuretic torasemide (T), and 50 mg/die of furosemide (F)." | 9.08 | [Comparison between torasemide and furosemide in the treatment of ascites in cirrhotic patients]. ( Bodini, P; Dizioli, P; Marelli, A; Quinzani, M; Reggiani, A; Tonghini, L, 1997) |
| "In a randomized double-blind trial we compared the effects of torasemide, a new loop diuretic, and furosemide in nonazotemic cirrhotic patients with ascites during a 3-day period in association with potassium canrenoate (200 mg/day) administration." | 9.07 | Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study. ( Azzena, G; Buzzelli, G; De Feo, ML; Gentilini, P; La Villa, G; Laffi, G; Marra, F; Meacci, E, 1991) |
| "1 Thirty in-patients of both sexes suffering from ascitic liver cirrhosis were divided into three groups treated with (a) a placebo, (b) ibopamine (SB 7505, a new oral dopaminergic drug) and (c) frusemide, for 10 days." | 9.05 | Effectiveness of ibopamine in the management of ascitic liver cirrhosis--a controlled study v placebo and frusemide. ( Bauer, R; Ghirardi, P; Melloni, GF; Melloni, R; Minoja, GM; Piatto, E; Scarazzati, E, 1981) |
| "Nonsteroidal anti-inflammatory drugs (NSAID) suppress prostaglandin-dependent renal blood flow and furosemide-induced diuresis in patients with cirrhosis and ascites." | 9.05 | Sulindac and indomethacin suppress the diuretic action of furosemide in patients with cirrhosis and ascites: evidence that sulindac affects renal prostaglandins. ( Daskalopoulos, G; Gonzalez, M; Katkov, W; Kronborg, I; Laffi, G; Zipser, RD, 1985) |
| "Previous clinical studies have reported that furosemide can be used to treat liver cirrhosis (LC) effectively." | 9.01 | Efficacy of furosemide for treatment of liver cirrhosis: A systematic review protocol of randomized controlled trial. ( Ding, ZM; Li, Y; Liu, WL; Zhu, ZR, 2019) |
| " Our group has shown that treatment of patients with diuretic-resistant heart failure with high-dose furosemide plus hypertonic saline is effective and well tolerated, improving symptoms of congestion, reducing plasma levels of markers of neurohormonal and inflammatory activation, decreasing hospital readmission rates, and reducing long-term mortality." | 8.87 | Intravenous high-dose furosemide and hypertonic saline solutions for refractory heart failure and ascites. ( Licata, G; Parrinello, G; Pinto, A; Tuttolomondo, A, 2011) |
| "To evaluate the clinical usefulness of combined furosemide and human albumin for the treatment of diuretic-resistant edema in patients with nephrotic syndrome and cirrhosis." | 8.82 | Combined furosemide and human albumin treatment for diuretic-resistant edema. ( Eisele, G; Elwell, RJ; Spencer, AP, 2003) |
| "This review concerns studies of the comparative efficacy and safety of torasemide and furosemide in patients with cirrhosis of the liver complicated by ascites and oedema." | 8.79 | Comparative analysis of torasemide and furosemide in liver cirrhosis. ( Elia, GF; Fiaccadori, F; Pasetti, GC; Pedretti, G; Pizzaferri, P, 1994) |
| "Ninety cirrhotic patients with ascites were studied after administration of HSS infusion (n=25) or etilefrine tablets (n=25), or both (n=25) plus standard diuretics therapy (SDT), or SDT alone (n=15)." | 8.12 | Effects of adding hypertonic saline solutions and/or etilefrine to standard diuretics therapy in cirrhotic patients with ascites. ( Badra, G; El-Haggar, S; El-Said, H; Ibrahim, O; Radwan, H, 2022) |
| "Among 459 patients with hepatic edema enrolled in a retrospective, multicenter collaborative study, we analyzed 407 patients who received tolvaptan." | 7.96 | Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema. ( Abe, H; Arai, T; Atsukawa, M; Chuma, M; Fukunishi, S; Hattori, N; Hiraoka, A; Iio, E; Ikegami, T; Itokawa, N; Iwakiri, K; Iwasa, M; Kato, K; Kondo, C; Kumada, T; Michitaka, K; Nakagawa-Iwashita, A; Nozaki, A; Okubo, H; Okubo, T; Senoh, T; Tada, T; Takaguchi, K; Takei, Y; Tanaka, Y; Tani, J; Toyoda, H; Tsubota, A; Tsutsui, A; Uojima, H; Watanabe, T; Yokohama, K; Yoshida, Y, 2020) |
| "The proportion of furosemide administration was higher in patients with cramping compared with those without." | 7.96 | Effect of furosemide on muscle cramps in patients with liver cirrhosis. ( Akahane, T; Fujinaga, Y; Furukawa, M; Kaji, K; Kawaratani, H; Kubo, T; Mitoro, A; Moriya, K; Namisaki, T; Saikawa, S; Sato, S; Sawada, Y; Shimozato, N; Takaya, H; Yoshiji, H, 2020) |
| "Therapeutic response to tolvaptan was associated with longer survival in cirrhosis patients complicated with ascites." | 7.91 | Positive Response to Tolvaptan Treatment Would Be a Good Prognostic Factor for Cirrhotic Patients with Ascites. ( Kida, Y, 2019) |
| "We evaluated the metabolic and inflammatory effects of intravenous high-dose furosemide plus hypertonic saline solutions (HSS) compared with repeated paracentesis and a standard oral diuretic schedule, in patients with cirrhosis and refractory ascites." | 7.83 | Immune-Inflammatory and Metabolic Effects of High Dose Furosemide plus Hypertonic Saline Solution (HSS) Treatment in Cirrhotic Subjects with Refractory Ascites. ( Bellia, C; Ciaccio, M; Clemente, G; Di Bona, D; Di Raimondo, D; Gulotta, E; Maida, C; Pecoraro, R; Pinto, A; Simonetta, I; Tuttolomondo, A; Vassallo, V, 2016) |
| "Tolvaptan is a new drug used for treating ascites induced by liver cirrhosis, and it is covered by health insurance in Japan." | 7.81 | Re-response to tolvaptan after furosemide dose reduction in a patient with refractory ascites. ( Goto, A; Matsumoto, M; Nakamura, M; Sakaida, I; Terai, S, 2015) |
| "To verify prospectively the usefulness of the furosemide-induced natriuresis test in predicting ascites control by medical treatment, 15 stable cirrhotics (9 male) with ascites were studied." | 7.73 | The significance of the furosemide test for predicting ascites control by diuretics in cirrhotics: a comparison with volume expansion and octreotide infusion. ( Apollonio, L; Bartoli, EG; Fabris, C; Pirisi, M; Sereti, K; Toniutto, P, 2006) |
| "In out-patient departments, the measurement of urine sodium 8 hours after administrating 80 mg of intravenous furosemide, will help in differentiating ascites patients with lower treatment response to diuretics." | 7.72 | [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis]. ( Cho, HS; Choi, HS; Hahm, JS; Kim, JB; Kim, YH; Lee, MH; Lee, OY; Park, GT; Shim, SG, 2003) |
| "The effect of spironolactone on renal magnesium excretion under both basal conditions and conditions of frusemide-induced diuresis was studied in 11 control subjects with normal hepatic and renal function and in 12 patients with liver cirrhosis and ascites." | 7.68 | Attenuation by spironolactone of the magnesiuric effect of acute frusemide administration in patients with liver cirrhosis and ascites. ( Mayopoulou-Symvoulidou, D; Mountokalakis, TD; Stergiou, GS, 1993) |
| "We describe the successful use of combined ascitic-fluid and furosemide infusion as a therapeutic option in the management of massive diuretic-resistant ascites and severe oliguria of hepatic cirrhosis in a 30-year-old Nigerian male farmer." | 7.68 | Combined ascitic--fluid and furosemide infusion: a therapeutic option for massive diuretic-resistant ascites and severe oliguria of hepatic cirrhosis. ( Ijoma, CK; Nusiem, CA; Nwaneri, O; Offodile, AA; Onuigbo, MA; Onyeagocha, AC; Ozoh, JO, 1991) |
| "Plasma concentrations of atrial natriuretic factor (ANF) and cyclic 3',5'-guanosine monophosphate (cGMP) were measured in 11 cirrhotic patients with ascites, 11 cirrhotic patients without ascites and 15 control subjects." | 7.68 | Atrial natriuretic factor, cyclic 3',5'-guanosine monophosphate and prostaglandin E2 in liver cirrhosis: relation to blood volume and changes in blood volume after furosemide. ( Jensen, L; Jespersen, B; Pedersen, EB; Sørensen, SS, 1990) |
| "Propranolol hydrochloride is reported to lower portal pressure and inhibit renin secretion in patients with chronic liver disease, actions that might lessen the tendency to ascites formation." | 7.67 | Propranolol in the treatment of cirrhotic ascites. ( Rector, WG; Reynolds, TB, 1984) |
| "In cirrhotic patients low-dose captopril seems to be efficient in the treatment of ascites resistant to diuretics without causing major side effects." | 7.67 | [Effect of captopril therapy on sodium and water excretion in patients with liver cirrhosis and ascites]. ( Brunkhorst, R; Koch, K; Kühn, K; Schmidt, FW; Wrenger, E, 1989) |
| "Furosemide, 20 mg, was given intravenously as a bolus to seven patients with cirrhotic ascites and a 10-mg intravenous bolus dose was given to three normal subjects." | 7.66 | Furosemide kinetics in patients with hepatic cirrhosis with ascites. ( Fuller, R; Hoppel, C; Ingalls, ST, 1981) |
| "Mobilization of ascites was studied in 20 anesthetized dogs with experimental cirrhosis following a mannitol- or furosemide-induced diuresis." | 7.66 | Mobilization of ascites in cirrhotic dogs following furosemide or mannitol diuresis. ( Levy, M; Richard, C, 1978) |
| " To develop an effective but safe regimen for treatment of cirrhotic ascites, a two-part crossover study was done." | 6.64 | An optimal diuretic regimen for cirrhotic ascites. A controlled trial evaluating safety and efficacy of spironolactone and furosemide. ( Fuller, RK; Gobezie, GC; Khambatta, PB, 1977) |
| "A 73-year-old man with liver cirrhosis and advanced chronic kidney disease was admitted to our hospital due to bilateral lower leg edema and appetite loss." | 5.51 | Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease. ( Akimoto, T; Kobayashi, T; Maeshima, A; Masuda, T; Matsuoka, R; Murakami, T; Muto, S; Nagata, D; Nagayama, I; Nakagawa, S; Ohara, K; Saito, O, 2019) |
| "This study aimed to assess the influence to the renal function by furosemide dose reductions after administration of tolvaptan in cirrhotic ascites patients." | 5.34 | Furosemide Dose Changes Associated with Furosemide/Tolvaptan Combination Therapy in Patients with Cirrhosis. ( Hidaka, H; Kako, M; Koizumi, W; Kubota, K; Nakazawa, T; Shibuya, A; Sung, JH; Tanaka, Y; Uojima, H; Wada, N, 2020) |
| " Identification of patients who will not respond to diuretic therapy usually requires several weeks of observation during which a trial of diuretics is instituted using stepwise increases in dosage in order to classify ascites as refractory." | 5.31 | Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites. ( Pomier-Layrargues, G; Spahr, L; Tran, HK; Villeneuve, JP, 2001) |
| "Furosemide treatment was performed in 26 HC patients." | 5.28 | [Effect of furosemide on the renal prostaglandin system in liver cirrhosis with ascites]. ( Dustov, AD; Mansurov, KhKh, 1989) |
| " We randomly assigned patients with cirrhosis and uncomplicated ascites who were treated with anti-aldosteronic drugs (≥200 mg/day) and furosemide (≥25 mg/day) to receive either standard medical treatment (SMT) or SMT plus HA (40 g twice weekly for 2 weeks, and then 40 g weekly) for up to 18 months." | 5.27 | Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. ( Airoldi, A; Alessandria, C; Andrealli, A; Angeli, P; Angelico, M; Baldassarre, M; Ballardini, G; Bernardi, M; Boccia, S; Cacciola, I; Cappa, FM; Caraceni, P; Cavallin, M; Cesarini, L; Cozzolongo, R; De Marco, R; Di Marco, V; Elia, C; Elia, G; Fagiuoli, S; Federico, A; Fidone, F; Foschi, FG; Galioto, A; Guarisco, R; Levantesi, F; Massironi, S; Morisco, F; Nardelli, S; Neri, S; Pasquale, C; Piano, S; Prestianni, L; Rendina, M; Riggio, O; Romanelli, RG; Roncadori, A; Ruggeri, M; Sangiovanni, V; Simone, L; Svegliati-Baroni, G; Toniutto, P; Tortora, A; Tufoni, M; Zaccherini, G, 2018) |
| " According to the increased urinary excretion of unchanged furosemide in patients with cirrhosis of the liver, the pharmacodynamic effect of the drug is enhanced: In the first 4-h-collecting period the excretion of water, chloride and sodium is significantly more increased than in the control group." | 5.27 | Pharmacokinetics and pharmacodynamic effects of furosemide in patients with liver cirrhosis. ( Häntze, R; Jorke, D; Keil, E; Krombholz, B; Penzlin, M; Reinhardt, M; Traeger, A, 1985) |
| " Patients without hyperkalemia were administrated 100 mg of spironolactone/day." | 5.22 | High Dose Oral Furosemide with Salt Ingestion in the Treatment of Refractory Ascites of Liver Cirrhosis. ( Demir, M; Dogan, O; Ozer, B; Parlakgumus, A; Serin, E; Yakar, T, 2016) |
| "To compare the safety and efficacy of intravenous high-dose furosemide + hypertonic saline solutions (HSS) with repeated paracentesis in patients with cirrhosis and refractory ascites." | 5.14 | Clinical Trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites. ( Cammà, C; Craxì, A; Di Raimondo, D; Di Sciacca, R; Licata, A; Licata, G; Parrinello, G; Paterna, S; Pinto, A; Tuttolomondo, A, 2009) |
| "Satavaptan treatment was associated with a decrease in ascites (mean change in body weight was -0." | 5.14 | Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia--a randomized, double-blind, placebo-controlled study. ( Bruha, R; Dudley, F; Ginès, P; Terg, R; Watson, H; Wong, F; Zarski, JP, 2010) |
| "Tolvaptan was orally administrated at titrated doses of 15, 30, and 60 mg once daily after breakfast for 3 days at each dose to 18 liver cirrhosis patients with persistent ascites and/or lower limb edema despite receiving oral furosemide at 40 mg/day or higher." | 5.14 | A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis. ( Chayama, K; Kaneko, A; Kato, M; Murawaki, Y; Okada, M; Okita, K; Ono, N; Sakaida, I; Sata, M; Yoshihara, H; Yoshihara, N, 2010) |
| "To conduct a randomized, double-blind, placebo-controlled, cross-over study to test the hypothesis that midodrine significantly increases natriuretic response of IV furosemide in non-azotemic cirrhotics with ascites." | 5.14 | The effects of midodrine on the natriuretic response to furosemide in cirrhotics with ascites. ( Chalasani, N; Hamman, M; Jones, D; Kahi, C; Kwo, PY; Misra, VL; Vuppalanchi, R, 2010) |
| "Twenty nonazotemic cirrhotic patients with ascites were treated with furosemide and spironolactone." | 5.12 | The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites. ( Economou, M; Kalambokis, G; Kosta, P; Papadimitriou, K; Tsianos, EV, 2006) |
| "To investigate the safety and tolerability of RWJ-351647 compared with placebo after single oral dose administration to patients with cirrhosis and ascites, on a stable treatment with furosemide and spironolactone." | 5.12 | Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study. ( Korula, J; Maheshwari, A; Parikh, C; Schrier, RW; Steare, S; Thuluvath, PJ; Wong, F; Yoo, HW, 2006) |
| "The effects of the addition of clonidine to diuretics on the mobilization of ascites in the short term (diuretic response and requirement of diuretics) and the long term (readmissions for tense ascites and requirement of diuretics) were examined in patients with cirrhosis and with increased sympathetic nervous system (SNS) activity." | 5.12 | Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system. ( Codden, T; Henry, JP; Lenaerts, A; Ligny, G; Meunier, JC, 2006) |
| "To evaluate the changes in renal functional mass as reflected by DMSA uptake after single injection of intravenous furosemide in patients with compensated liver cirrhosis." | 5.12 | The changes in renal function after a single dose of intravenous furosemide in patients with compensated liver cirrhosis. ( Assy, N; Gorenberg, M; Hussein, O; Kayal, M; Mejirisky, Y; Schlesinger, S, 2006) |
| " This investigation consists of a double-blind, randomized, placebo-controlled trial aimed at comparing the effects of the selective COX-2 inhibitor celecoxib (200 mg every 12 hours for a total of 5 doses) on platelet and renal function and the renal response to furosemide (40 mg intravenously) with those of naproxen (500 mg every 12 hours for a total of 5 doses) and placebo in 28 patients with cirrhosis and ascites." | 5.11 | Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites. ( Arroyo, V; Clària, J; Escolar, G; Ginès, P; Jiménez, W; Kent, JD; López-Parra, M; Ruiz-Del-Arbol, L; Vucelic, B, 2005) |
| "The most rational treatment of moderate ascites is spironolactone alone or in combination with furosemide." | 5.10 | Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety. ( Cabré, E; Durández, R; Gassull, MA; Granada, ML; Jiménez, JA; Morillas, RM; Pardo, A; Planas, R; Quintero, E; Santos, J, 2003) |
| "These results show that torsemide is as effective and safe as frusemide for long-term treatment of cirrhotic patients with ascites." | 5.09 | Long-term efficacy of torsemide compared with frusemide in cirrhotic patients with ascites. ( Abecasis, R; Cobas, S; Guevara, M; Miguez, C; Terg, R, 2001) |
| "To evaluate the pharmacokinetics and pharmacodynamics of furosemide and torasemide in patients with cirrhosis and diuretic resistant ascites." | 5.08 | Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites. ( Bernareggi, A; Buzzelli, G; Carloni, V; Chibbaro, G; Cotrozzi, G; Foschi, M; Gentilini, P; La Villa, G; Laffi, G; Marra, F; Melani, L; Quartini, M; Simoni, A; Tommasi, AC, 1996) |
| "Twenty patients with cirrhosis and ascites were randomly divided in two groups to receive 20 mg/die of the new-loop-diuretic torasemide (T), and 50 mg/die of furosemide (F)." | 5.08 | [Comparison between torasemide and furosemide in the treatment of ascites in cirrhotic patients]. ( Bodini, P; Dizioli, P; Marelli, A; Quinzani, M; Reggiani, A; Tonghini, L, 1997) |
| "In a prospective randomized short-term study, the efficacy and safety of xipamide and a combination of spironolactone and furosemide were compared in the treatment of hepatic cirrhotic ascites." | 5.07 | Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide. ( Knauf, H; Mutschler, E, 1994) |
| " Both drugs were administered in association with spironolactone (200 mg/day) in 28 nonazotemic cirrhotic patients with controlled ascites." | 5.07 | Torasemide versus furosemide in cirrhosis: a long-term, double-blind, randomized clinical study. ( Elia, G; Fiaccadori, F; Pasetti, G; Pedretti, G; Pizzaferri, P, 1993) |
| "The effects of torasemide (20 mg/day) and furosemide (50 mg/day), each given over 4 days, were compared in a randomized and crossover study carried out in seven patients with cirrhosis and tense ascites." | 5.07 | Torasemide in the treatment of patients with cirrhosis and ascites. ( Carloni, V; Foschi, M; Gentilini, P; La Villa, G; Laffi, G; Marra, F; Romanelli, RG, 1993) |
| "Forty patients with cirrhosis of the liver and tense ascites were randomized to receive either aldactone 400 mg/day and furosemide 80 mg/day (n = 20) or repeated large volume paracentesis (LVP) and infusion of low molecular weight dextran (n = 20)." | 5.07 | Large volume paracentesis and intravenous dextran to treat tense ascites. ( Acharya, SK; Balwinder, S; Nijhawan, S; Padhee, AK; Tandon, BN, 1992) |
| "The effect of propranolol on furosemide-stimulated urinary prostaglandin E2 (PGE2) excretion and renal blood flow was evaluated in 12 patients with alcoholic liver cirrhosis." | 5.07 | Effect of propranolol on urinary prostaglandin E2 excretion and renal interlobar arterial blood flow after furosemide administration in patients with hepatic cirrhosis. ( Bilić, A; Ljubicić, N; Plavsić, V, 1992) |
| "In a randomized double-blind trial we compared the effects of torasemide, a new loop diuretic, and furosemide in nonazotemic cirrhotic patients with ascites during a 3-day period in association with potassium canrenoate (200 mg/day) administration." | 5.07 | Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study. ( Azzena, G; Buzzelli, G; De Feo, ML; Gentilini, P; La Villa, G; Laffi, G; Marra, F; Meacci, E, 1991) |
| "In a randomized prospective study the efficacy and side effects of xipamide versus the combination spironolactone/furosemide in the treatment of cirrhotic ascites were studied." | 5.06 | Prediction of diuretic mobilization of cirrhotic ascites by pretreatment fractional sodium excretion. ( Gerok, W; Goerg, KJ; Knauf, H; Leser, HG; Mutschler, E; Schölmerich, J; Wenk, E, 1990) |
| "To compare the efficacy of three commonly used diuretic regimens in the treatment of ascites, we randomized 90 patients to three treatment groups: Sequential Spironolactone (spironolactone followed by furosemide if necessary), Combination (spironolactone and furosemide in combination), and Furosemide (furosemide given alone)." | 5.05 | Diuresis in the ascitic patient: a randomized controlled trial of three regimens. ( Fogel, MR; Gregory, PB; Knauer, CM; Miller, RG; Neal, EA; Sawhney, VK, 1981) |
| "1 Thirty in-patients of both sexes suffering from ascitic liver cirrhosis were divided into three groups treated with (a) a placebo, (b) ibopamine (SB 7505, a new oral dopaminergic drug) and (c) frusemide, for 10 days." | 5.05 | Effectiveness of ibopamine in the management of ascitic liver cirrhosis--a controlled study v placebo and frusemide. ( Bauer, R; Ghirardi, P; Melloni, GF; Melloni, R; Minoja, GM; Piatto, E; Scarazzati, E, 1981) |
| "Nonsteroidal anti-inflammatory drugs (NSAID) suppress prostaglandin-dependent renal blood flow and furosemide-induced diuresis in patients with cirrhosis and ascites." | 5.05 | Sulindac and indomethacin suppress the diuretic action of furosemide in patients with cirrhosis and ascites: evidence that sulindac affects renal prostaglandins. ( Daskalopoulos, G; Gonzalez, M; Katkov, W; Kronborg, I; Laffi, G; Zipser, RD, 1985) |
| "Previous clinical studies have reported that furosemide can be used to treat liver cirrhosis (LC) effectively." | 5.01 | Efficacy of furosemide for treatment of liver cirrhosis: A systematic review protocol of randomized controlled trial. ( Ding, ZM; Li, Y; Liu, WL; Zhu, ZR, 2019) |
| "Furosemide is a loop diuretic frequently used to treat fluid overload conditions such as hepatic cirrhosis and congestive heart failure (CHF)." | 4.90 | Population-based meta-analysis of furosemide pharmacokinetics. ( Mager, DE; Mallikaarjun, S; Shoaf, SE; Van Wart, SA, 2014) |
| " Our group has shown that treatment of patients with diuretic-resistant heart failure with high-dose furosemide plus hypertonic saline is effective and well tolerated, improving symptoms of congestion, reducing plasma levels of markers of neurohormonal and inflammatory activation, decreasing hospital readmission rates, and reducing long-term mortality." | 4.87 | Intravenous high-dose furosemide and hypertonic saline solutions for refractory heart failure and ascites. ( Licata, G; Parrinello, G; Pinto, A; Tuttolomondo, A, 2011) |
| "In patients with heart failure (HF), torsemide demonstrated decreased mortality compared with furosemide in 1 study (2." | 4.85 | A comprehensive review of the loop diuretics: should furosemide be first line? ( Banta, WM; Wargo, KA, 2009) |
| "To evaluate the clinical usefulness of combined furosemide and human albumin for the treatment of diuretic-resistant edema in patients with nephrotic syndrome and cirrhosis." | 4.82 | Combined furosemide and human albumin treatment for diuretic-resistant edema. ( Eisele, G; Elwell, RJ; Spencer, AP, 2003) |
| " Torsemide, and other loop diuretics such as furosemide, are indicated for the treatment of edema associated with congestive heart failure, renal disease, and hepatic disease." | 4.79 | Torsemide: a pyridine-sulfonylurea loop diuretic. ( Adams, KF; Blose, JS; Patterson, JH, 1995) |
| "This review concerns studies of the comparative efficacy and safety of torasemide and furosemide in patients with cirrhosis of the liver complicated by ascites and oedema." | 4.79 | Comparative analysis of torasemide and furosemide in liver cirrhosis. ( Elia, GF; Fiaccadori, F; Pasetti, GC; Pedretti, G; Pizzaferri, P, 1994) |
| "Ninety cirrhotic patients with ascites were studied after administration of HSS infusion (n=25) or etilefrine tablets (n=25), or both (n=25) plus standard diuretics therapy (SDT), or SDT alone (n=15)." | 4.12 | Effects of adding hypertonic saline solutions and/or etilefrine to standard diuretics therapy in cirrhotic patients with ascites. ( Badra, G; El-Haggar, S; El-Said, H; Ibrahim, O; Radwan, H, 2022) |
| "This study investigated time-course changes in skeletal muscle volume per year with tolvaptan in patients with refractory ascites that was unresponsive to loop diuretics and aldosterone antagonists." | 3.96 | Management of refractory ascites attenuates muscle mass reduction and improves survival in patients with decompensated cirrhosis. ( Aikata, H; Chayama, K; Fujino, H; Hiramatsu, A; Imamura, M; Kawaoka, T; Kodama, K; Morio, K; Murakami, E; Nakahara, T; Namba, M; Ohya, K; Tsuge, M; Uchikawa, S; Yamauchi, M, 2020) |
| "Among 459 patients with hepatic edema enrolled in a retrospective, multicenter collaborative study, we analyzed 407 patients who received tolvaptan." | 3.96 | Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema. ( Abe, H; Arai, T; Atsukawa, M; Chuma, M; Fukunishi, S; Hattori, N; Hiraoka, A; Iio, E; Ikegami, T; Itokawa, N; Iwakiri, K; Iwasa, M; Kato, K; Kondo, C; Kumada, T; Michitaka, K; Nakagawa-Iwashita, A; Nozaki, A; Okubo, H; Okubo, T; Senoh, T; Tada, T; Takaguchi, K; Takei, Y; Tanaka, Y; Tani, J; Toyoda, H; Tsubota, A; Tsutsui, A; Uojima, H; Watanabe, T; Yokohama, K; Yoshida, Y, 2020) |
| "The proportion of furosemide administration was higher in patients with cramping compared with those without." | 3.96 | Effect of furosemide on muscle cramps in patients with liver cirrhosis. ( Akahane, T; Fujinaga, Y; Furukawa, M; Kaji, K; Kawaratani, H; Kubo, T; Mitoro, A; Moriya, K; Namisaki, T; Saikawa, S; Sato, S; Sawada, Y; Shimozato, N; Takaya, H; Yoshiji, H, 2020) |
| "Therapeutic response to tolvaptan was associated with longer survival in cirrhosis patients complicated with ascites." | 3.91 | Positive Response to Tolvaptan Treatment Would Be a Good Prognostic Factor for Cirrhotic Patients with Ascites. ( Kida, Y, 2019) |
| "We evaluated the metabolic and inflammatory effects of intravenous high-dose furosemide plus hypertonic saline solutions (HSS) compared with repeated paracentesis and a standard oral diuretic schedule, in patients with cirrhosis and refractory ascites." | 3.83 | Immune-Inflammatory and Metabolic Effects of High Dose Furosemide plus Hypertonic Saline Solution (HSS) Treatment in Cirrhotic Subjects with Refractory Ascites. ( Bellia, C; Ciaccio, M; Clemente, G; Di Bona, D; Di Raimondo, D; Gulotta, E; Maida, C; Pecoraro, R; Pinto, A; Simonetta, I; Tuttolomondo, A; Vassallo, V, 2016) |
| "Tolvaptan is a new drug used for treating ascites induced by liver cirrhosis, and it is covered by health insurance in Japan." | 3.81 | Re-response to tolvaptan after furosemide dose reduction in a patient with refractory ascites. ( Goto, A; Matsumoto, M; Nakamura, M; Sakaida, I; Terai, S, 2015) |
| " Kinetic parameters were determined in plasma and urine; further, in patients with liver cirrhosis, renal elimination kinetics of the diuretic were correlated with the concentration of direct plasma bilirubin, as a marker of cholestasis, at the beginning of a treatment with xipamide, 40 mg qd." | 3.73 | [Mechanism of action of xipamide and its classification as a "low ceiling diuretic". Pharmacodynamic-pharmacokinetic studies in healthy volunteers and in kidney and liver patients]. ( Knauf, H; Mutschler, E, 2005) |
| "To verify prospectively the usefulness of the furosemide-induced natriuresis test in predicting ascites control by medical treatment, 15 stable cirrhotics (9 male) with ascites were studied." | 3.73 | The significance of the furosemide test for predicting ascites control by diuretics in cirrhotics: a comparison with volume expansion and octreotide infusion. ( Apollonio, L; Bartoli, EG; Fabris, C; Pirisi, M; Sereti, K; Toniutto, P, 2006) |
| "In out-patient departments, the measurement of urine sodium 8 hours after administrating 80 mg of intravenous furosemide, will help in differentiating ascites patients with lower treatment response to diuretics." | 3.72 | [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis]. ( Cho, HS; Choi, HS; Hahm, JS; Kim, JB; Kim, YH; Lee, MH; Lee, OY; Park, GT; Shim, SG, 2003) |
| "A 49-year-old man with liver cirrhosis and hypertension was found to have hyperkalemia out of a degree of renal insufficiency and metabolic acidosis with low to normal anion gap, aggravated by volume contraction with diarrhea and medications (captopril, spironolactone and atenolol) interfering with potassium homeostasis." | 3.68 | Hyperkalemia due to hyporeninemic hypoaldosteronism with liver cirrhosis and hypertension. ( Ahn, YH; Chang, DK; Choi, JW; Kee, CS; Kim, HJ, 1993) |
| "The effect of spironolactone on renal magnesium excretion under both basal conditions and conditions of frusemide-induced diuresis was studied in 11 control subjects with normal hepatic and renal function and in 12 patients with liver cirrhosis and ascites." | 3.68 | Attenuation by spironolactone of the magnesiuric effect of acute frusemide administration in patients with liver cirrhosis and ascites. ( Mayopoulou-Symvoulidou, D; Mountokalakis, TD; Stergiou, GS, 1993) |
| "We describe the successful use of combined ascitic-fluid and furosemide infusion as a therapeutic option in the management of massive diuretic-resistant ascites and severe oliguria of hepatic cirrhosis in a 30-year-old Nigerian male farmer." | 3.68 | Combined ascitic--fluid and furosemide infusion: a therapeutic option for massive diuretic-resistant ascites and severe oliguria of hepatic cirrhosis. ( Ijoma, CK; Nusiem, CA; Nwaneri, O; Offodile, AA; Onuigbo, MA; Onyeagocha, AC; Ozoh, JO, 1991) |
| "Plasma concentrations of atrial natriuretic factor (ANF) and cyclic 3',5'-guanosine monophosphate (cGMP) were measured in 11 cirrhotic patients with ascites, 11 cirrhotic patients without ascites and 15 control subjects." | 3.68 | Atrial natriuretic factor, cyclic 3',5'-guanosine monophosphate and prostaglandin E2 in liver cirrhosis: relation to blood volume and changes in blood volume after furosemide. ( Jensen, L; Jespersen, B; Pedersen, EB; Sørensen, SS, 1990) |
| "Propranolol hydrochloride is reported to lower portal pressure and inhibit renin secretion in patients with chronic liver disease, actions that might lessen the tendency to ascites formation." | 3.67 | Propranolol in the treatment of cirrhotic ascites. ( Rector, WG; Reynolds, TB, 1984) |
| "In cirrhotic patients low-dose captopril seems to be efficient in the treatment of ascites resistant to diuretics without causing major side effects." | 3.67 | [Effect of captopril therapy on sodium and water excretion in patients with liver cirrhosis and ascites]. ( Brunkhorst, R; Koch, K; Kühn, K; Schmidt, FW; Wrenger, E, 1989) |
| "The pharmacokinetics of furosemide was studied in 7 patients with diagnosed liver cirrhosis and in 7 healthy subjects." | 3.66 | Pharmacokinetics of furosemide in patients with hepatic cirrhosis. ( Antezana, C; Arancibia, A; Caro, P; González, G; Rivas, MI, 1982) |
| " Graded single intravenous (100-1600 mg) or peroral (100-400 mg) doses were administered to six patients with ascites due to liver cirrhosis without and during basic treatment with spironolactone." | 3.66 | Comparison of azosemide and furosemide in ascitic patients without and during administration of spironolactone. ( Gercsák, G; Hartai, A; Molnár, Z; Radó, JP, 1982) |
| "Furosemide, 20 mg, was given intravenously as a bolus to seven patients with cirrhotic ascites and a 10-mg intravenous bolus dose was given to three normal subjects." | 3.66 | Furosemide kinetics in patients with hepatic cirrhosis with ascites. ( Fuller, R; Hoppel, C; Ingalls, ST, 1981) |
| "After rapid intravenous injection of furosemide 40 mg (Fu), plasma levels were determined in 7 healthy volunteers, 8 patients with liver cirrhosis with ascites and 7 patients with end-stage renal disease (ESRD)." | 3.66 | Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide. ( Hoppe-Seyler, G; Keller, E; Mumm, R; Schollmeyer, P, 1981) |
| "The binding of three loop diuretics, piretanide, bumetanide and furosemide, to serum proteins from patients with liver cirrhosis or fulminant hepatitis was investigated using equilibrium dialysis." | 3.66 | Further investigations on the binding of loop diuretics to serum proteins from patients with liver disease. ( Fujii, S; Fujiwara, K; Goto, S; Miyamoto, A; Nakayama, T; Yamada, H; Yoshitomi, H, 1981) |
| "Five patients with hepatorenal syndrome were treated with a LeVeen peritoneovenous shunt and furosemide." | 3.66 | Treatment of hepatorenal syndrome. ( Schwartz, ML; Vogel, SB, 1980) |
| "Mobilization of ascites was studied in 20 anesthetized dogs with experimental cirrhosis following a mannitol- or furosemide-induced diuresis." | 3.66 | Mobilization of ascites in cirrhotic dogs following furosemide or mannitol diuresis. ( Levy, M; Richard, C, 1978) |
| "Fifty patients with Child-Pugh C liver cirrhosis and tense ascites were randomly allocated into 5 groups." | 2.71 | Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial. ( Degoricija, V; Marout, J; Sefer, S; Troskot, B; Zjacic-Rotkvic, V, 2003) |
| "In order to clarify debated issues of the medical treatment of ascites in cirrhosis--the usefulness of a low sodium diet and washout period preceding diuretic administration, maximal dosage of antimineralocorticoid to be reached before the addition of a loop diuretic, identifications of factors influencing treatment efficacy--115 hospitalized patients with non-azotemic cirrhosis and ascites were recruited and randomized to receive a diet providing either 40 or 120 mmol of sodium daily." | 2.67 | Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content. ( Azzena, G; Bernardi, M; Bonato, S; Gasbarrini, G; Gentilini, P; Laffi, G; Marra, F; Naccarato, R; Salvagnini, M; Trevisani, F, 1993) |
| " This was in accordance with the pharmacokinetic behaviour of torasemide and furosemide." | 2.66 | Comparison of diuretic effects and pharmacokinetics of torasemide and furosemide after a single oral dose in patients with hydropically decompensated cirrhosis of the liver. ( Brunner, G; Häcker, W; von Bergmann, K; von Möllendorff, E, 1988) |
| " To develop an effective but safe regimen for treatment of cirrhotic ascites, a two-part crossover study was done." | 2.64 | An optimal diuretic regimen for cirrhotic ascites. A controlled trial evaluating safety and efficacy of spironolactone and furosemide. ( Fuller, RK; Gobezie, GC; Khambatta, PB, 1977) |
| "Spironolactone has long been a standard for the treatment of cirrhotic ascites because it directly antagonizes aldosterone." | 2.38 | Medical treatment of ascites in cirrhosis. ( Gerbes, AL, 1993) |
| "Lastly, in patients with congestive heart failure, with intravenous administration, resistance represents a pharmacodynamic phenomenon." | 2.37 | Resistance to loop diuretics. Why it happens and what to do about it. ( Brater, DC, 1985) |
| "Sarcoidosis is a multisystem granulomatous inflammatory disorder frequently affecting the lungs, but also the liver, along with cirrhosis and portal hypertension occurring in less than 1% of the patients." | 1.51 | Finger clubbing and cirrhosis in a sarcoidosis patient. ( Bilir, M; Tetikkurt, C; Yanardag, H, 2019) |
| "A 73-year-old man with liver cirrhosis and advanced chronic kidney disease was admitted to our hospital due to bilateral lower leg edema and appetite loss." | 1.51 | Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease. ( Akimoto, T; Kobayashi, T; Maeshima, A; Masuda, T; Matsuoka, R; Murakami, T; Muto, S; Nagata, D; Nagayama, I; Nakagawa, S; Ohara, K; Saito, O, 2019) |
| "Furosemide was considered a long-term therapy for almost all patients (98." | 1.46 | Potentially inappropriate use of furosemide in a very elderly population: An observational study. ( Asgassou, S; d'Athis, P; Dipanda, M; Guepet, H; Manckoundia, P; Mazen, E; Menu, D; Perrin, S; Putot, A; Rodriguez-Cillero, C, 2017) |
| "Ascites, variceal bleeding, hepatic encephalopathy, and hepatorenal syndrome are among the complications you are likely to encounter when caring for a patient with cirrhosis." | 1.42 | Cirrhosis complications: keeping them under control. ( Eliacin, I; Kashan, S; Minor, SE; Whisenant, EB, 2015) |
| " The pharmacokinetic parameters were estimated using previously developed barrier-limited and space-distributed models." | 1.36 | Liver fibrosis impairs hepatic pharmacokinetics of liver transplant drugs in the rat model. ( Asadian, P; Crawford, DH; Fletcher, LM; Khlentzos, AM; Li, P; Liu, X; Roberts, MS; Robertson, TA; Thorling, CA; Zou, YH, 2010) |
| " Identification of patients who will not respond to diuretic therapy usually requires several weeks of observation during which a trial of diuretics is instituted using stepwise increases in dosage in order to classify ascites as refractory." | 1.31 | Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites. ( Pomier-Layrargues, G; Spahr, L; Tran, HK; Villeneuve, JP, 2001) |
| "Ascites in liver cirrhosis is a symptom of advanced liver disease, and liver transplantation should always be considered in eligible patients." | 1.31 | [Therapeutic program for ascites. Recommendations from the Swedish Society of Gastroenterology and Gastrointestinal Endoscopy]. ( Lööf, L; Prytz, H; Söderlund, C; Wallerstedt, S, 2001) |
| "Furosemide kinetics were not affected in patients with hepatic cirrhosis but the effect was lower than in the controls: urinary excretion of sodium (0." | 1.29 | Lack of effect of cimetidine on furosemide kinetics and dynamics in patients with hepatic cirrhosis. ( du Souich, P; Lambert, C; Sanchis Closa, A, 1993) |
| " These results show that long-term administration of spironolactone to patients with cirrhosis and no ascites produced a significant reduction in HVPG that may have been due to gradual, sustained volume contraction." | 1.29 | Plasma volume contraction in portal hypertension. ( Aramaki, T; Katsuta, Y; Okumura K [corrected to Okumura, H]; Okumura, H; Satomura, K; Sekiyama, T, 1993) |
| " Our data demonstrated a significant reduction in the hepatic venous pressure gradient on a chronic administration of spironolactone, which may have been due to volume contractions in patients with cirrhosis and no ascites." | 1.28 | Reduction in hepatic venous pressure gradient as a consequence of volume contraction due to chronic administration of spironolactone in patients with cirrhosis and no ascites. ( Akaike, M; Aramaki, T; Katsuta, Y; Komeichi, H; Ohsuga, M; Okumura, H; Satomura, K; Sekiyama, T; Terada, H; Tsutsui, H, 1991) |
| "Furosemide caused an increase in creatinine clearance in 15 patients (group A: 99 +/- 7 vs." | 1.28 | Renal prostacyclin influences renal function in non-azotemic cirrhotic patients treated with furosemide. ( Labarga, P; Milazzo, A; Prieto, J; Quiroga, J; Rodríguez-Ortigosa, CM; Zozaya, JM, 1991) |
| "Furosemide treatment was performed in 26 HC patients." | 1.28 | [Effect of furosemide on the renal prostaglandin system in liver cirrhosis with ascites]. ( Dustov, AD; Mansurov, KhKh, 1989) |
| " Clinical pharmacokinetics and diuretic effect of furosemide after oral administration of two dosage forms were also studied with 3 normal subjects and 3 cirrhotic patients." | 1.27 | Clinical pharmacokinetics and diuretic effect of furosemide in plain tablet and retard capsule with normal subjects and cirrhotic patients. ( Amano, J; Isozaki, S; Nakagawa, F; Oka, H; Saitoh, Y; Tamura, Z; Tanaka, N; Uchino, K, 1983) |
| "Drug-induced hepatic encephalopathy was more common in cirrhotics receiving diuretics (13." | 1.27 | An intensive drug monitoring study suggesting possible clinical irrelevance of impaired drug disposition in liver disease. ( Busto, U; Janecek, E; Kaplan, K; Naranjo, CA; Roach, CA; Ruiz, I, 1983) |
| "Because hyponatremia is frequently associated with preceding diuretic treatment and unrestricted fluid intake--conditions which have not been addressed sufficiently in published literature--we studied the pathophysiology and the clinical setting of such hyponatremia in a large group of internal medicine patients." | 1.27 | Role of diuretics, hormonal derangements, and clinical setting of hyponatremia in medical patients. ( Gross, P; Hackenthal, E; Hausmann, C; Ketteler, M; Rascher, W; Reinhard, C; Ritz, E; Schömig, A, 1988) |
| "Triamterene is a potassium-sparing diuretic used in patients with cirrhosis for the treatment of ascites." | 1.27 | Kinetics and dynamics of triamterene at steady-state in patients with cirrhosis. ( Dao, MT; Villeneuve, JP, 1988) |
| " According to the increased urinary excretion of unchanged furosemide in patients with cirrhosis of the liver, the pharmacodynamic effect of the drug is enhanced: In the first 4-h-collecting period the excretion of water, chloride and sodium is significantly more increased than in the control group." | 1.27 | Pharmacokinetics and pharmacodynamic effects of furosemide in patients with liver cirrhosis. ( Häntze, R; Jorke, D; Keil, E; Krombholz, B; Penzlin, M; Reinhardt, M; Traeger, A, 1985) |
| "Patients suffering from liver cirrhosis with ascites showed significantly higher arginine vasopressin levels, approaching normal values, when ascites was under control." | 1.26 | Improved method and its clinical application of a radioimmunoassay of arginine vasopressin in human serum. ( Franz, HE; Maier, V; Wagner, H, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 173 (63.60) | 18.7374 |
| 1990's | 42 (15.44) | 18.2507 |
| 2000's | 23 (8.46) | 29.6817 |
| 2010's | 27 (9.93) | 24.3611 |
| 2020's | 7 (2.57) | 2.80 |
| Authors | Studies |
|---|---|
| Duvvuri, PD | 1 |
| Bhardwaj, C | 1 |
| Wattanakit, K | 1 |
| Radwan, H | 1 |
| Ibrahim, O | 1 |
| Badra, G | 1 |
| El-Said, H | 1 |
| El-Haggar, S | 1 |
| Stevens, LJ | 1 |
| Dubbeld, J | 1 |
| Doppenberg, JB | 1 |
| van Hoek, B | 1 |
| Menke, AL | 1 |
| Donkers, JM | 1 |
| Alsharaa, A | 1 |
| de Vries, A | 1 |
| Vaes, WHJ | 1 |
| Knibbe, CAJ | 1 |
| van de Steeg, E | 1 |
| Alwayn, IPJ | 1 |
| Namba, M | 1 |
| Hiramatsu, A | 1 |
| Aikata, H | 1 |
| Kodama, K | 1 |
| Uchikawa, S | 1 |
| Ohya, K | 1 |
| Morio, K | 1 |
| Fujino, H | 1 |
| Nakahara, T | 1 |
| Murakami, E | 1 |
| Yamauchi, M | 1 |
| Kawaoka, T | 1 |
| Tsuge, M | 1 |
| Imamura, M | 1 |
| Chayama, K | 2 |
| Yanardag, H | 1 |
| Tetikkurt, C | 1 |
| Bilir, M | 1 |
| Atsukawa, M | 1 |
| Tsubota, A | 1 |
| Takaguchi, K | 1 |
| Toyoda, H | 1 |
| Iwasa, M | 2 |
| Ikegami, T | 1 |
| Chuma, M | 1 |
| Nozaki, A | 1 |
| Uojima, H | 3 |
| Hiraoka, A | 1 |
| Fukunishi, S | 1 |
| Yokohama, K | 1 |
| Tada, T | 1 |
| Kato, K | 1 |
| Abe, H | 1 |
| Tani, J | 1 |
| Okubo, H | 1 |
| Watanabe, T | 1 |
| Hattori, N | 1 |
| Tsutsui, A | 1 |
| Senoh, T | 1 |
| Yoshida, Y | 1 |
| Okubo, T | 1 |
| Itokawa, N | 1 |
| Nakagawa-Iwashita, A | 1 |
| Kondo, C | 1 |
| Arai, T | 1 |
| Michitaka, K | 1 |
| Iio, E | 1 |
| Kumada, T | 1 |
| Tanaka, Y | 2 |
| Takei, Y | 2 |
| Iwakiri, K | 1 |
| Rodriguez-Cillero, C | 1 |
| Menu, D | 1 |
| d'Athis, P | 1 |
| Perrin, S | 1 |
| Dipanda, M | 1 |
| Asgassou, S | 1 |
| Guepet, H | 1 |
| Mazen, E | 1 |
| Manckoundia, P | 1 |
| Putot, A | 1 |
| Gunathilaka, ML | 1 |
| Niriella, MA | 1 |
| Luke, NV | 1 |
| Piyarathna, CL | 1 |
| Siriwardena, RC | 1 |
| De Silva, AP | 1 |
| de Silva, HJ | 1 |
| Hidaka, H | 3 |
| Nakayama, T | 2 |
| Sung, JH | 2 |
| Ichita, C | 1 |
| Tokoro, S | 1 |
| Masuda, S | 1 |
| Sasaki, A | 1 |
| Koizumi, K | 1 |
| Egashira, H | 1 |
| Kako, M | 2 |
| Caraceni, P | 1 |
| Riggio, O | 1 |
| Angeli, P | 2 |
| Alessandria, C | 1 |
| Neri, S | 1 |
| Foschi, FG | 1 |
| Levantesi, F | 1 |
| Airoldi, A | 1 |
| Boccia, S | 1 |
| Svegliati-Baroni, G | 1 |
| Fagiuoli, S | 1 |
| Romanelli, RG | 3 |
| Cozzolongo, R | 1 |
| Di Marco, V | 1 |
| Sangiovanni, V | 1 |
| Morisco, F | 1 |
| Toniutto, P | 2 |
| Tortora, A | 1 |
| De Marco, R | 1 |
| Angelico, M | 1 |
| Cacciola, I | 1 |
| Elia, G | 2 |
| Federico, A | 1 |
| Massironi, S | 1 |
| Guarisco, R | 1 |
| Galioto, A | 2 |
| Ballardini, G | 1 |
| Rendina, M | 1 |
| Nardelli, S | 1 |
| Piano, S | 1 |
| Elia, C | 1 |
| Prestianni, L | 1 |
| Cappa, FM | 1 |
| Cesarini, L | 1 |
| Simone, L | 1 |
| Pasquale, C | 1 |
| Cavallin, M | 1 |
| Andrealli, A | 1 |
| Fidone, F | 1 |
| Ruggeri, M | 1 |
| Roncadori, A | 1 |
| Baldassarre, M | 1 |
| Tufoni, M | 1 |
| Zaccherini, G | 1 |
| Bernardi, M | 4 |
| Kida, Y | 1 |
| Nagayama, I | 1 |
| Masuda, T | 1 |
| Nakagawa, S | 1 |
| Murakami, T | 1 |
| Ohara, K | 1 |
| Matsuoka, R | 1 |
| Kobayashi, T | 1 |
| Maeshima, A | 1 |
| Akimoto, T | 1 |
| Saito, O | 1 |
| Muto, S | 1 |
| Nagata, D | 1 |
| Zhu, ZR | 1 |
| Liu, WL | 1 |
| Ding, ZM | 1 |
| Li, Y | 1 |
| Wada, N | 1 |
| Kubota, K | 1 |
| Nakazawa, T | 1 |
| Shibuya, A | 1 |
| Koizumi, W | 1 |
| Ishihara, T | 1 |
| Kato, M | 2 |
| Isoai, A | 1 |
| Kobayashi, R | 1 |
| Torii, N | 1 |
| Soneda, N | 1 |
| Sawada, Y | 1 |
| Kawaratani, H | 1 |
| Kubo, T | 1 |
| Fujinaga, Y | 1 |
| Furukawa, M | 1 |
| Saikawa, S | 1 |
| Sato, S | 1 |
| Takaya, H | 1 |
| Kaji, K | 1 |
| Shimozato, N | 1 |
| Moriya, K | 1 |
| Namisaki, T | 1 |
| Akahane, T | 1 |
| Mitoro, A | 1 |
| Yoshiji, H | 1 |
| Zhu, YF | 1 |
| Gu, XB | 1 |
| Zhu, HY | 1 |
| Yang, XJ | 1 |
| Wang, D | 1 |
| Yu, P | 1 |
| Van Wart, SA | 1 |
| Shoaf, SE | 1 |
| Mallikaarjun, S | 1 |
| Mager, DE | 1 |
| Goto, A | 1 |
| Terai, S | 1 |
| Nakamura, M | 1 |
| Matsumoto, M | 1 |
| Sakaida, I | 2 |
| Henriksen, UL | 1 |
| Kiszka-Kanowitz, M | 1 |
| Bendtsen, F | 1 |
| Henriksen, JH | 1 |
| Minor, SE | 1 |
| Eliacin, I | 1 |
| Kashan, S | 1 |
| Whisenant, EB | 1 |
| Yakar, T | 1 |
| Demir, M | 1 |
| Dogan, O | 1 |
| Parlakgumus, A | 1 |
| Ozer, B | 1 |
| Serin, E | 1 |
| Tuttolomondo, A | 3 |
| Di Raimondo, D | 2 |
| Bellia, C | 1 |
| Clemente, G | 1 |
| Pecoraro, R | 1 |
| Maida, C | 1 |
| Simonetta, I | 1 |
| Vassallo, V | 1 |
| Di Bona, D | 1 |
| Gulotta, E | 1 |
| Ciaccio, M | 1 |
| Pinto, A | 3 |
| Licata, G | 2 |
| Licata, A | 1 |
| Parrinello, G | 2 |
| Di Sciacca, R | 1 |
| Cammà, C | 1 |
| Craxì, A | 1 |
| Paterna, S | 1 |
| Fasolato, S | 1 |
| Mazza, E | 1 |
| Okolicsanyi, L | 1 |
| Maresio, G | 1 |
| Velo, E | 1 |
| Salinas, F | 1 |
| D'Aquino, M | 1 |
| Sticca, A | 1 |
| Gatta, A | 1 |
| Hou, W | 1 |
| Sanyal, AJ | 1 |
| Wargo, KA | 1 |
| Banta, WM | 1 |
| Ginès, P | 6 |
| Wong, F | 3 |
| Watson, H | 1 |
| Terg, R | 2 |
| Bruha, R | 1 |
| Zarski, JP | 1 |
| Dudley, F | 1 |
| Okita, K | 1 |
| Okada, M | 1 |
| Kaneko, A | 1 |
| Sata, M | 1 |
| Yoshihara, H | 1 |
| Yoshihara, N | 1 |
| Ono, N | 1 |
| Murawaki, Y | 1 |
| Kountouras, J | 1 |
| Zavos, C | 1 |
| Touloumis, L | 1 |
| Chatzopoulos, D | 1 |
| Kalambokis, G | 4 |
| Tsianos, EV | 4 |
| Zou, YH | 1 |
| Liu, X | 1 |
| Khlentzos, AM | 1 |
| Asadian, P | 1 |
| Li, P | 1 |
| Thorling, CA | 1 |
| Robertson, TA | 1 |
| Fletcher, LM | 1 |
| Crawford, DH | 1 |
| Roberts, MS | 1 |
| Misra, VL | 1 |
| Vuppalanchi, R | 1 |
| Jones, D | 1 |
| Hamman, M | 1 |
| Kwo, PY | 1 |
| Kahi, C | 1 |
| Chalasani, N | 3 |
| Rosario, M | 1 |
| Song, SX | 1 |
| McCullough, LD | 1 |
| Degoricija, V | 1 |
| Zjacic-Rotkvic, V | 1 |
| Marout, J | 1 |
| Sefer, S | 1 |
| Troskot, B | 1 |
| Elwell, RJ | 1 |
| Spencer, AP | 1 |
| Eisele, G | 1 |
| Santos, J | 1 |
| Planas, R | 5 |
| Pardo, A | 1 |
| Durández, R | 1 |
| Cabré, E | 1 |
| Morillas, RM | 1 |
| Granada, ML | 1 |
| Jiménez, JA | 1 |
| Quintero, E | 3 |
| Gassull, MA | 1 |
| Pantaleo, P | 1 |
| Marra, F | 5 |
| Vizzutti, F | 1 |
| Spadoni, S | 1 |
| Ciabattoni, G | 1 |
| Galli, C | 1 |
| La Villa, G | 5 |
| Gentilini, P | 7 |
| Laffi, G | 7 |
| LARIZZA, P | 2 |
| BRUNETTI, P | 2 |
| NENCI, G | 2 |
| COLI, L | 2 |
| STOKES, W | 1 |
| ROBSON, AO | 1 |
| KERR, DN | 1 |
| ASHCROFT, R | 1 |
| TEASDALE, G | 1 |
| KOENIGSTEIN, RP | 1 |
| BERMAN, LB | 1 |
| EBRAHIMI, A | 1 |
| LEDERBOGEN, K | 1 |
| HUEDEPOHL, M | 1 |
| EL-BADRY, R | 1 |
| KHALIFA, K | 1 |
| EL-AYADI, A | 1 |
| EL-SAFORI, S | 1 |
| TOPUZADA, S | 2 |
| BJORNEBOE, M | 1 |
| VILLANI, M | 1 |
| FORTUNATO, F | 1 |
| MARCHESE, G | 1 |
| STOCCHI, F | 1 |
| FERRUCCI, A | 2 |
| CIURLI, GC | 1 |
| CHIARA, F | 1 |
| ZUCCHELLI, GP | 1 |
| POZZI, L | 1 |
| MADULI, S | 1 |
| CAMPANINI, H | 1 |
| COMOLI, G | 1 |
| GAMBIGLIANIZOCCOLI, A | 1 |
| PELTOLA, P | 1 |
| LEONDEFF, J | 1 |
| MASTRANGELO, F | 1 |
| D AGOSTINO, F | 1 |
| PASTORE, G | 1 |
| BARACCHI, G | 1 |
| CAPPAI, G | 1 |
| GIACOMASSO, P | 1 |
| Cho, HS | 1 |
| Park, GT | 1 |
| Kim, YH | 1 |
| Shim, SG | 1 |
| Kim, JB | 1 |
| Lee, OY | 1 |
| Choi, HS | 1 |
| Hahm, JS | 1 |
| Lee, MH | 1 |
| Clària, J | 1 |
| Kent, JD | 1 |
| López-Parra, M | 1 |
| Escolar, G | 1 |
| Ruiz-Del-Arbol, L | 1 |
| Jiménez, W | 2 |
| Vucelic, B | 1 |
| Arroyo, V | 7 |
| Knauf, H | 4 |
| Mutschler, E | 4 |
| Economou, M | 2 |
| Fotopoulos, A | 1 |
| Bokharhii, JA | 1 |
| Katsaraki, A | 1 |
| Kosta, P | 1 |
| Papadimitriou, K | 1 |
| Thuluvath, PJ | 1 |
| Maheshwari, A | 1 |
| Yoo, HW | 1 |
| Schrier, RW | 2 |
| Parikh, C | 1 |
| Steare, S | 1 |
| Korula, J | 1 |
| Lenaerts, A | 2 |
| Codden, T | 2 |
| Meunier, JC | 2 |
| Henry, JP | 2 |
| Ligny, G | 2 |
| Pirisi, M | 1 |
| Fabris, C | 1 |
| Apollonio, L | 1 |
| Sereti, K | 1 |
| Bartoli, EG | 1 |
| Assy, N | 1 |
| Kayal, M | 1 |
| Mejirisky, Y | 1 |
| Gorenberg, M | 1 |
| Hussein, O | 1 |
| Schlesinger, S | 1 |
| Mehta, RL | 1 |
| Cantarovich, F | 1 |
| Shaw, A | 1 |
| Hoste, E | 1 |
| Murray, P | 1 |
| Wertheimer, L | 1 |
| Almondhiry, H | 1 |
| Khero, B | 1 |
| King, JC | 1 |
| Majeron, PL | 1 |
| Martinoli, E | 1 |
| Stinco, G | 1 |
| Shafei, AZ | 1 |
| Habib, YA | 1 |
| el-Khangry, HA | 1 |
| Abou-Khair, SA | 1 |
| Abaza, HH | 1 |
| Nibal, AH | 1 |
| Bufalari, A | 1 |
| Meloni, G | 1 |
| Marmo, R | 1 |
| Persico, M | 1 |
| Costume, A | 1 |
| Bronzino, P | 1 |
| Del Vecchio, E | 1 |
| Gentile, S | 1 |
| Porcellini, M | 1 |
| Migneco, G | 1 |
| Mascarella, A | 1 |
| Tripi, S | 1 |
| La Cascia, C | 1 |
| Di Caro, R | 1 |
| Pérez-Ayuso, RM | 2 |
| Gaya, J | 1 |
| Bory, F | 3 |
| Rimola, A | 4 |
| Rivera, F | 1 |
| Rodés, J | 4 |
| Descos, L | 1 |
| Gauthier, A | 1 |
| Levy, VG | 2 |
| Michel, H | 1 |
| Quinton, A | 1 |
| Rueff, B | 1 |
| Fermanian, J | 1 |
| Fombonne, E | 1 |
| Durbec, JP | 1 |
| Boer, HH | 1 |
| Nelson, RW | 1 |
| Long, GG | 1 |
| Rector, WG | 2 |
| Reynolds, TB | 2 |
| Uchino, K | 2 |
| Isozaki, S | 2 |
| Amano, J | 1 |
| Tanaka, N | 2 |
| Saitoh, Y | 2 |
| Nakagawa, F | 2 |
| Tamura, Z | 2 |
| Oka, H | 1 |
| Fossati, C | 1 |
| Boyer, TD | 1 |
| Warnock, DG | 1 |
| Bartoli, E | 1 |
| Satta, A | 1 |
| Faedda, R | 1 |
| Olmeo, NA | 1 |
| Soggia, G | 1 |
| Branca, G | 1 |
| Naranjo, CA | 2 |
| Busto, U | 2 |
| Janecek, E | 1 |
| Ruiz, I | 2 |
| Roach, CA | 1 |
| Kaplan, K | 1 |
| Anderson, GH | 1 |
| Anderson, T | 1 |
| Streeten, DH | 1 |
| Schroeder, ET | 1 |
| Davies, IB | 1 |
| Lightman, SL | 1 |
| Gross, P | 2 |
| Handelman, W | 1 |
| Fogel, MR | 1 |
| Sawhney, VK | 1 |
| Neal, EA | 1 |
| Miller, RG | 1 |
| Knauer, CM | 1 |
| Gregory, PB | 1 |
| Melloni, GF | 1 |
| Minoja, GM | 1 |
| Melloni, R | 1 |
| Piatto, E | 1 |
| Scarazzati, E | 1 |
| Bauer, R | 1 |
| Ghirardi, P | 1 |
| Verbeeck, RK | 2 |
| Patwardhan, RV | 1 |
| Villeneuve, JP | 4 |
| Wilkinson, GR | 2 |
| Branch, RA | 2 |
| González, G | 2 |
| Arancibia, A | 1 |
| Rivas, MI | 1 |
| Caro, P | 1 |
| Antezana, C | 1 |
| Capussotti, L | 1 |
| Aricò, S | 1 |
| Marucci, M | 1 |
| Dellepiane, M | 1 |
| De La Pierre, M | 1 |
| Radó, JP | 4 |
| Molnár, Z | 1 |
| Hartai, A | 1 |
| Gercsák, G | 1 |
| Pupita, F | 2 |
| Ansuini, R | 1 |
| Frausini, G | 1 |
| Fuller, R | 1 |
| Hoppel, C | 1 |
| Ingalls, ST | 1 |
| Mauro, G | 1 |
| Cantino, G | 1 |
| Vigiani, L | 1 |
| Keller, E | 1 |
| Hoppe-Seyler, G | 1 |
| Mumm, R | 1 |
| Schollmeyer, P | 1 |
| Goto, S | 1 |
| Yoshitomi, H | 1 |
| Miyamoto, A | 1 |
| Yamada, H | 1 |
| Fujii, S | 1 |
| Fujiwara, K | 1 |
| Schwartz, ML | 1 |
| Vogel, SB | 1 |
| Milani, A | 2 |
| Ciammella, AM | 2 |
| Rossi, L | 2 |
| Albillos, A | 1 |
| Lledó, JL | 1 |
| Rossi, I | 1 |
| Pérez-Páramo, M | 1 |
| Tabuenca, MJ | 1 |
| Bañares, R | 1 |
| Iborra, J | 1 |
| Garrido, A | 1 |
| Escartín, P | 1 |
| Bosch, J | 2 |
| Blose, JS | 1 |
| Adams, KF | 1 |
| Patterson, JH | 1 |
| Jespersen, B | 2 |
| Fogh-Andersen, N | 1 |
| Brock, A | 1 |
| Sogni, P | 1 |
| Soupison, T | 1 |
| Moreau, R | 2 |
| Le Moine, O | 1 |
| Bacq, Y | 1 |
| Hadengue, A | 1 |
| Lebrec, D | 2 |
| Fiaccadori, F | 2 |
| Pasetti, GC | 1 |
| Pedretti, G | 2 |
| Pizzaferri, P | 2 |
| Elia, GF | 1 |
| Kee, CS | 1 |
| Choi, JW | 1 |
| Chang, DK | 1 |
| Ahn, YH | 1 |
| Kim, HJ | 1 |
| Sanchis Closa, A | 1 |
| Lambert, C | 1 |
| du Souich, P | 1 |
| Salerno, F | 1 |
| Lorenzano, E | 1 |
| Maggi, A | 1 |
| Badalamenti, S | 2 |
| Minuz, P | 1 |
| Degan, M | 1 |
| Chinea, B | 1 |
| Scotti, A | 1 |
| Gerbes, AL | 2 |
| Bertheau-Reitha, U | 1 |
| Falkner, C | 1 |
| Jüngst, D | 1 |
| Paumgartner, G | 1 |
| Salvagnini, M | 1 |
| Azzena, G | 2 |
| Bonato, S | 1 |
| Trevisani, F | 2 |
| Gasbarrini, G | 2 |
| Naccarato, R | 2 |
| Pasetti, G | 1 |
| Stergiou, GS | 1 |
| Mayopoulou-Symvoulidou, D | 1 |
| Mountokalakis, TD | 1 |
| Carloni, V | 2 |
| Foschi, M | 2 |
| Katsuta, Y | 2 |
| Aramaki, T | 2 |
| Sekiyama, T | 2 |
| Satomura, K | 2 |
| Okumura, H | 2 |
| Okumura K [corrected to Okumura, H] | 1 |
| Bissoli, F | 1 |
| Gini, G | 1 |
| Bosio, M | 1 |
| Ceriani, R | 1 |
| Melani, L | 1 |
| Cotrozzi, G | 1 |
| Quartini, M | 1 |
| Chibbaro, G | 1 |
| Tommasi, AC | 1 |
| Bernareggi, A | 1 |
| Simoni, A | 1 |
| Buzzelli, G | 3 |
| Chang, SC | 1 |
| Chang, HI | 1 |
| Chen, FJ | 1 |
| Shiao, GM | 1 |
| Wang, SS | 1 |
| Lee, SD | 1 |
| Marelli, A | 1 |
| Bodini, P | 1 |
| Reggiani, A | 1 |
| Quinzani, M | 1 |
| Dizioli, P | 1 |
| Tonghini, L | 1 |
| Nasraway, SA | 1 |
| Xia, H | 1 |
| Xia, Y | 1 |
| Lo, J | 1 |
| Casini-Raggi, V | 1 |
| Di Fiore, G | 1 |
| Pinzani, M | 1 |
| Blendis, L | 1 |
| Spahr, L | 1 |
| Tran, HK | 1 |
| Pomier-Layrargues, G | 1 |
| Abecasis, R | 1 |
| Guevara, M | 1 |
| Miguez, C | 1 |
| Cobas, S | 1 |
| Gorski, JC | 2 |
| Horlander, JC | 2 |
| Craven, R | 2 |
| Hoen, H | 2 |
| Maya, J | 2 |
| Brater, DC | 4 |
| Van Cauter, J | 1 |
| Lööf, L | 1 |
| Prytz, H | 1 |
| Söderlund, C | 1 |
| Wallerstedt, S | 1 |
| Wilkinson, SP | 2 |
| Wheeler, PG | 2 |
| Smith, IK | 1 |
| Williams, R | 2 |
| Fuller, RK | 1 |
| Khambatta, PB | 1 |
| Gobezie, GC | 1 |
| Thompson, EJ | 1 |
| Torres, E | 1 |
| Grosberg, SJ | 1 |
| Martinez-Maldonado, M | 2 |
| Epstien, M | 1 |
| Castagnolo, B | 1 |
| De Colibus, V | 1 |
| Napolitano, L | 1 |
| Aliperta, A | 1 |
| Caldarelli, G | 1 |
| Abignente, F | 1 |
| Blendis, LM | 2 |
| Greig, PD | 1 |
| Langer, B | 1 |
| Baigrie, RS | 1 |
| Ruse, J | 1 |
| Taylor, BR | 1 |
| Margolick, JB | 1 |
| Zulik, R | 1 |
| Dreux, C | 1 |
| Passa, P | 1 |
| Halter, D | 1 |
| Smith, T | 1 |
| Golindano, C | 1 |
| Alam, AN | 1 |
| Edmonds, CJ | 1 |
| Noël, P | 1 |
| Levy, M | 1 |
| Richard, C | 1 |
| Borirakchanyavat, V | 1 |
| Sitprija, V | 1 |
| Apra, RM | 1 |
| Corvalán, A | 1 |
| Kshirsagar, NA | 1 |
| Gupta, KC | 1 |
| Paul, T | 1 |
| Shah, BP | 1 |
| Vora, KK | 1 |
| Sanghvi, B | 1 |
| Acharya, VN | 1 |
| Mehta, JM | 2 |
| Sheth, UK | 2 |
| Pontigo, E | 1 |
| Valdenegro, C | 1 |
| Wagner, H | 1 |
| Maier, V | 1 |
| Franz, HE | 1 |
| Lucas, CE | 1 |
| Zito, JG | 1 |
| Carter, KM | 1 |
| Cortez, A | 1 |
| Stebner, FC | 1 |
| Werning, C | 1 |
| Vetter, H | 1 |
| Vetter, W | 1 |
| Beckerhoff, R | 1 |
| Glänzer, K | 1 |
| Furrer, J | 1 |
| Hahn, C | 1 |
| Kolloch, R | 1 |
| Krück, F | 1 |
| Kutz, K | 1 |
| Siegenthaler, W | 1 |
| Witassek, F | 1 |
| Ruffo, A | 1 |
| Motta, G | 1 |
| Coltorti, M | 1 |
| Radaeli, E | 1 |
| Ciaccio, S | 1 |
| Corsini, R | 1 |
| Trebbi, R | 1 |
| Liehr, H | 1 |
| Grün, M | 1 |
| Thiel, H | 1 |
| Bianchi Porre, G | 1 |
| Lazzaroni, M | 1 |
| Petrillo, M | 1 |
| Müting, D | 1 |
| Fischer, R | 1 |
| Ordnung, W | 1 |
| van Vliet, AA | 1 |
| Hackeng, WH | 1 |
| Donker, AJ | 1 |
| Meuwissen, SG | 1 |
| Acharya, SK | 1 |
| Balwinder, S | 1 |
| Padhee, AK | 1 |
| Nijhawan, S | 1 |
| Tandon, BN | 1 |
| Hagège, H | 1 |
| Ink, O | 1 |
| Ducreux, M | 1 |
| Pelletier, G | 1 |
| Buffet, C | 1 |
| Etienne, JP | 1 |
| Ljubicić, N | 1 |
| Bilić, A | 1 |
| Plavsić, V | 1 |
| Yersin, B | 1 |
| Monova, D | 1 |
| Belovezhdov, N | 1 |
| Onuigbo, MA | 1 |
| Ozoh, JO | 1 |
| Nusiem, CA | 1 |
| Onyeagocha, AC | 1 |
| Nwaneri, O | 1 |
| Offodile, AA | 1 |
| Ijoma, CK | 1 |
| Parikh, SS | 1 |
| Amarapurkar, DN | 1 |
| Viswanath, N | 1 |
| Desai, HG | 1 |
| Kalro, RH | 1 |
| Jensen, L | 1 |
| Sørensen, SS | 1 |
| Pedersen, EB | 1 |
| Akaike, M | 1 |
| Terada, H | 1 |
| Ohsuga, M | 1 |
| Komeichi, H | 1 |
| Tsutsui, H | 1 |
| Meacci, E | 1 |
| De Feo, ML | 1 |
| Quiroga, J | 1 |
| Zozaya, JM | 1 |
| Labarga, P | 1 |
| Rodríguez-Ortigosa, CM | 1 |
| Milazzo, A | 1 |
| Prieto, J | 1 |
| Wenk, E | 1 |
| Schölmerich, J | 1 |
| Goerg, KJ | 1 |
| Gerok, W | 1 |
| Leser, HG | 1 |
| Tesar, V | 1 |
| Kotal, P | 1 |
| Petrtýl, J | 1 |
| Bukovská, J | 1 |
| Kozáková, M | 1 |
| Brodanová, M | 1 |
| Horký, K | 1 |
| Kordac, V | 1 |
| Bardi, A | 5 |
| Orozco, R | 2 |
| Sapunar, J | 1 |
| Fernández, I | 2 |
| Mansurov, KhKh | 1 |
| Dustov, AD | 1 |
| Brunkhorst, R | 1 |
| Wrenger, E | 1 |
| Kühn, K | 1 |
| Schmidt, FW | 1 |
| Koch, K | 1 |
| Hattori, K | 1 |
| Yauchi, T | 1 |
| Minato, Y | 1 |
| Hasumura, Y | 1 |
| Takeuchi, J | 1 |
| Shiigai, T | 1 |
| Cereda, JM | 1 |
| Roulot, D | 1 |
| Braillon, A | 1 |
| Koshy, A | 1 |
| Viver, J | 2 |
| Cabrera, J | 2 |
| Ketteler, M | 1 |
| Hausmann, C | 1 |
| Reinhard, C | 1 |
| Schömig, A | 1 |
| Hackenthal, E | 1 |
| Ritz, E | 1 |
| Rascher, W | 1 |
| Khvorostinka, VN | 1 |
| Teslenko, VG | 1 |
| Khvisiuk, SS | 1 |
| Kosenko, NP | 1 |
| Borisenko, GV | 1 |
| Brunner, G | 1 |
| von Bergmann, K | 1 |
| Häcker, W | 1 |
| von Möllendorff, E | 1 |
| Camps, J | 1 |
| Bruckstein, AH | 1 |
| Toyozaki, N | 1 |
| Suzuki, T | 1 |
| Ito, T | 2 |
| Dao, MT | 1 |
| Fawthrop, F | 1 |
| O'Hare, JP | 1 |
| Millar, N | 1 |
| Weston, CF | 1 |
| Read, AE | 1 |
| Kandel, G | 1 |
| Diamant, NE | 1 |
| De Palma, R | 1 |
| Santini, C | 1 |
| Servadei, D | 1 |
| Daskalopoulos, G | 1 |
| Kronborg, I | 1 |
| Katkov, W | 1 |
| Gonzalez, M | 1 |
| Zipser, RD | 1 |
| Parlapiano, C | 1 |
| Paoletti, V | 1 |
| Traeger, A | 1 |
| Häntze, R | 1 |
| Penzlin, M | 1 |
| Krombholz, B | 1 |
| Reinhardt, M | 1 |
| Keil, E | 1 |
| Jorke, D | 1 |
| Sturniolo, GC | 1 |
| Farini, R | 1 |
| D'Angelo, A | 1 |
| Ossi, E | 1 |
| Sherlock, S | 3 |
| Senewiratne, B | 3 |
| Scott, A | 2 |
| Walker, JG | 2 |
| Roux, M | 1 |
| Herne, N | 1 |
| Gilly, R | 1 |
| Michaud, J | 1 |
| Le Gall, F | 1 |
| Sonwalkar, AV | 1 |
| Wechalekar, MD | 1 |
| Wechalekar, DK | 1 |
| Waikar, SM | 1 |
| Bhala, BB | 1 |
| Borbély, L | 1 |
| Takó, J | 3 |
| Bános, C | 1 |
| Bodin, F | 1 |
| Liguory, C | 1 |
| Capelle, P | 1 |
| Conte, M | 1 |
| Ventura, E | 1 |
| Zeneroli, ML | 1 |
| Kato, T | 1 |
| Yoshitoski, Y | 1 |
| Huang, CM | 1 |
| Atkinson, AJ | 1 |
| Levin, M | 1 |
| Levin, NW | 1 |
| Quintanilla, A | 1 |
| Furrer, HU | 1 |
| Tönz, O | 1 |
| Tojo, S | 1 |
| Suzuki, H | 1 |
| Leemhuis, MP | 1 |
| Struyvenberg, A | 1 |
| Sadikali, F | 1 |
| Arieff, AI | 1 |
| Chidsey, CA | 1 |
| Shiikai, T | 1 |
| Ideura, T | 1 |
| Matsui, N | 1 |
| Koshikawa, S | 1 |
| Runeberg, L | 1 |
| Pasternack, A | 1 |
| Borgmästars, H | 1 |
| von Bonsdorff, M | 1 |
| Kommerell, B | 1 |
| Bajpai, PC | 1 |
| Hasan, M | 1 |
| Gupta, AK | 1 |
| Kunwar, KB | 1 |
| Sidorenko, BA | 2 |
| Kharchenko, VI | 2 |
| Titov, VN | 1 |
| Lotova, EV | 1 |
| Mel'nichenko, GA | 2 |
| Lowenthal, DT | 1 |
| Shear, L | 1 |
| Rudyk, BI | 1 |
| Kalbian, VV | 1 |
| Dölle, W | 1 |
| Chaudhury, RR | 1 |
| Chugh, KS | 1 |
| Gupta, GS | 1 |
| Sodhi, P | 1 |
| Gupta, KK | 1 |
| Kirkendall, WM | 1 |
| Stein, JH | 1 |
| Imler, M | 1 |
| Bockel, R | 1 |
| Peter, B | 1 |
| Kieny, R | 1 |
| Stahl, J | 1 |
| Szám, I | 2 |
| Sólyom, I | 1 |
| Fischer, J | 1 |
| Juul, J | 1 |
| Leiter, L | 1 |
| Marosi, J | 2 |
| Perez-Stable, EC | 1 |
| Materson, BJ | 2 |
| Jahrmärker, H | 1 |
| Anderton, JL | 1 |
| Kincaid-Smith, P | 1 |
| Dévényi, I | 1 |
| Papadoyanakis, N | 1 |
| Darsinos, J | 1 |
| Alexandrou, K | 1 |
| Karli, J | 1 |
| Bargnesi, P | 1 |
| Azzi, E | 1 |
| Perraro, F | 1 |
| Tolstykh, AN | 1 |
| Amer, ZM | 1 |
| Sheir, ZM | 1 |
| Gorgy, AN | 1 |
| Refaie, MR | 1 |
| Mohamed, AA | 1 |
| Sabbaga, E | 1 |
| Koperstych, S | 1 |
| de Faria, CV | 1 |
| Bemvenuti, GA | 1 |
| Job, JM | 1 |
| Riggio, G | 1 |
| Schnack, H | 1 |
| Dettli, L | 1 |
| Spring, P | 1 |
| Boivin, P | 1 |
| Fauvert, R | 1 |
| Eknoyan, G | 1 |
| Yium, JJ | 1 |
| Suki, WN | 1 |
| Buligescu, L | 1 |
| Candiori, R | 1 |
| Poliantseva, LP | 1 |
| Moiseev, VS | 1 |
| Ermolenko, VM | 1 |
| Alonso, HO | 1 |
| Gaspary, F | 1 |
| Turiella, RG | 1 |
| Tvrde, P | 1 |
| Nicastro, F | 1 |
| Bull, MB | 1 |
| Laragh, JH | 2 |
| Merino, I | 2 |
| Rendic, Y | 2 |
| Generini, G | 3 |
| Doerr, E | 1 |
| Plaza de los Reyes, M | 1 |
| Silvi, G | 1 |
| Ghiara, F | 1 |
| Grazia Franzò, M | 1 |
| Paolo Zucchelli, G | 1 |
| Herrmann, GR | 1 |
| Ghiselli, RG | 1 |
| Andrieu, J | 1 |
| Lesueur, G | 1 |
| Steigmann, F | 2 |
| Mejicano, R | 1 |
| Branciari, C | 1 |
| Lauro, G | 1 |
| Menghini, G | 1 |
| Nuti, M | 1 |
| el Badry, A | 1 |
| el Safori, S | 1 |
| Pickert, H | 1 |
| Müller, K | 1 |
| Henning, H | 1 |
| Oz, R | 1 |
| De Will, P | 1 |
| Dubin, A | 1 |
| Proto, C | 1 |
| Lieberman, FL | 1 |
| Joseph, DA | 1 |
| Vaidya, AB | 1 |
| Kapadia, J | 1 |
| Shah, MJ | 1 |
| De Los Reyes, MP | 1 |
| Carrillo, E | 1 |
| Arroyo, JL | 1 |
| Bueno, J | 1 |
| Rivero, A | 1 |
| Lucas, I | 1 |
| Ortiz de Landazuri, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Use of Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis: a Multicenter, Open-label Randomized Clinical Trial[NCT01288794] | Phase 4 | 431 participants (Actual) | Interventional | 2011-03-31 | Completed | ||
| Effects of Adding Hypertonic Saline Solutions and/or Etilefrine to Standard Diuretics Therapy in Egyptian Cirrhotic Patients With Ascites[NCT04785755] | Phase 2 | 90 participants (Actual) | Interventional | 2017-11-30 | Completed | ||
| Immune-inflammatory and Metabolic Effects of High Dose Furosemide Plus Hypertonic Saline Solution (HSS) Treatment in Cirrhotic Subjects With Refractory Ascite[NCT02821377] | Phase 2 | 40 participants (Actual) | Interventional | 2013-12-31 | Completed | ||
| Phase 4 Study on the Comparison Between Combined Versus Sequential Diuretic Treatment of Moderate Ascites in Nonazotemic Patients With Cirrhosis[NCT00741663] | Phase 4 | 100 participants (Anticipated) | Interventional | 2005-04-30 | Completed | ||
| Effect of Branched-chain Amino Acids (BCAA) to Muscle Cramps in Patients With Cirrhosis[NCT05724485] | Phase 4 | 50 participants (Anticipated) | Interventional | 2023-04-01 | Not yet recruiting | ||
| Potential Role of Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Ascites in Cirrhotic Patients[NCT05999773] | 40 participants (Anticipated) | Observational | 2023-07-15 | Recruiting | |||
| The Effects of Clonidine on the Diuretic Response in Cirrhotic Patients With Ascites and Activation of Sympathetic Nervous System: a Randomized Double-Blind Placebo Controlled Study.[NCT00356226] | 64 participants | Interventional | 2000-10-31 | Completed | |||
| Resistant Hypertension On Treatment - Sequential Nephron Blockade Compared to Dual Blockade of the Renin-angiotensin-aldosterone System Plus Bisoprolol in the Treatment of Resistant Arterial Hypertension: A Randomized Trial (ResHypOT)[NCT02832973] | Phase 4 | 72 participants (Actual) | Interventional | 2015-09-30 | Completed | ||
| Comparison of Success Rate and Complication Between Conventional Angiocatheter Versus New Anchoring Device (KARAHOC) Used for Paracentesis in Cirrhotic Patients With Ascites[NCT05578573] | 80 participants (Anticipated) | Interventional | 2022-01-17 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
25 reviews available for furosemide and Cirrhosis, Liver
| Article | Year |
|---|---|
Efficacy of furosemide for treatment of liver cirrhosis: A systematic review protocol of randomized controlled trial.
Topics: Diuretics; Furosemide; Humans; Liver Cirrhosis; Randomized Controlled Trials as Topic; Treatment Out | 2019 |
Population-based meta-analysis of furosemide pharmacokinetics.
Topics: Adult; Diuretics; Female; Furosemide; Heart Failure; Humans; Liver Cirrhosis; Male; Middle Aged; Mod | 2014 |
Ascites: diagnosis and management.
Topics: Ascites; Ascitic Fluid; Cardiac Output; Diet, Sodium-Restricted; Disease Progression; Diuretics; Dru | 2009 |
A comprehensive review of the loop diuretics: should furosemide be first line?
Topics: Furosemide; Heart Failure; Humans; Kidney Failure, Chronic; Liver Cirrhosis; Sodium Potassium Chlori | 2009 |
Intravenous high-dose furosemide and hypertonic saline solutions for refractory heart failure and ascites.
Topics: Ascites; Cardio-Renal Syndrome; Diuretics; Furosemide; Heart Failure; Humans; Infusions, Intravenous | 2011 |
Combined furosemide and human albumin treatment for diuretic-resistant edema.
Topics: Albumins; Ascites; Diuretics; Drug Therapy, Combination; Edema; Furosemide; Humans; Liver Cirrhosis; | 2003 |
[Hepatorenal syndrome. Clinical and pathogenetic aspects and therapeutic approach].
Topics: Dihydroergotoxine; Dopamine; Endotoxins; Furosemide; Hemodynamics; Humans; Kidney Diseases; Liver Ci | 1984 |
[Diuretics. II].
Topics: Acetazolamide; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antihypertensive Agents; Cardiac Glyc | 1981 |
Refractory oedema.
Topics: Aminophylline; Bumetanide; Diuretics; Drug Therapy, Combination; Edema; Edema, Cardiac; Ethacrynic A | 1980 |
[Evaluation and treatment of hyponatremia (author's transl)].
Topics: Furosemide; Heart Failure; Humans; Hypertonic Solutions; Hyponatremia; Inappropriate ADH Syndrome; I | 1980 |
Torsemide: a pyridine-sulfonylurea loop diuretic.
Topics: Clinical Trials as Topic; Diuretics; Drug Interactions; Furosemide; Heart Failure; Humans; Liver Cir | 1995 |
Comparative analysis of torasemide and furosemide in liver cirrhosis.
Topics: Clinical Trials as Topic; Diuretics; Edema; Furosemide; Humans; Liver Cirrhosis; Sulfonamides; Torse | 1994 |
Medical treatment of ascites in cirrhosis.
Topics: Ascites; Furosemide; Humans; Liver Cirrhosis; Spironolactone | 1993 |
Deranged renal function in liver disease.
Topics: Angiotensin II; Diet, Sodium-Restricted; Furosemide; Humans; Hyperaldosteronism; Kidney; Kidney Dise | 1977 |
Management of the patient with ascites.
Topics: Ascites; Bacterial Infections; Bed Rest; Diagnosis, Differential; Diuretics; Furosemide; Humans; Liv | 1987 |
Disposition and response to bumetanide and furosemide.
Topics: Adult; Aged; Biological Availability; Bumetanide; Diuretics; Furosemide; Heart Failure; Humans; Kidn | 1986 |
A clinical view of recent advances in ascites.
Topics: Animals; Ascites; Ascitic Fluid; Bacterial Infections; Blood Volume; Body Water; Extracellular Space | 1986 |
Resistance to loop diuretics. Why it happens and what to do about it.
Topics: Anti-Inflammatory Agents; Diet, Sodium-Restricted; Diuretics; Drug Interactions; Drug Resistance; Fu | 1985 |
Significance of hypokalaemia due to diuretics.
Topics: Amiloride; Arrhythmias, Cardiac; Chlorothiazide; Diuretics; Ethacrynic Acid; Extracellular Space; Fu | 1973 |
[Diuretic-resistant edema].
Topics: Adult; Aged; Animals; Body Fluids; Cats; Diet, Sodium-Restricted; Diuretics; Drug Resistance; Edema; | 1974 |
Clinical pharmacology of furosemide and ethacrynic acid.
Topics: Anuria; Diabetes Insipidus; Edema; Ethacrynic Acid; Furosemide; Heart Failure; Hemodynamics; Humans; | 1968 |
Combinations of diuretics in the treatment of edema.
Topics: Acetazolamide; Benzothiadiazines; Chlorthalidone; Diuretics; Edema; Ethacrynic Acid; Furosemide; Glu | 1970 |
Diuretic drug therapy of edema.
Topics: Ambulatory Care; Ascites; Body Weight; Chlorides; Diuresis; Diuretics; Edema; Ethacrynic Acid; Furos | 1971 |
[When and which diuretics? General and specific indications for diuretic therapy].
Topics: Acid-Base Equilibrium; Brain Edema; Diuresis; Diuretics; Edema; Ethacrynic Acid; Furosemide; Humans; | 1971 |
Diuretics. II. Clinical considerations.
Topics: Administration, Oral; Aminophylline; Ascites; Calcium; Carbohydrate Metabolism; Carbonic Anhydrase I | 1971 |
63 trials available for furosemide and Cirrhosis, Liver
| Article | Year |
|---|---|
Efficacy of combination therapy with natriuretic and aquaretic drugs in cirrhotic ascites patients: A randomized study.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Body Weig | 2017 |
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.
Topics: Aged; Albumins; Ascites; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Hyperkale | 2018 |
Furosemide Dose Changes Associated with Furosemide/Tolvaptan Combination Therapy in Patients with Cirrhosis.
Topics: Aged; Aged, 80 and over; Ascites; Body Weight; Dose-Response Relationship, Drug; Drug Therapy, Combi | 2020 |
[Influence of non-sodium restricted diet with diuretics on plasma rennin, renal blood flow and in patients with cirrhotic ascites].
Topics: Ascites; Chymosin; Diet, Sodium-Restricted; Diuretics; Female; Furosemide; Hepatitis B; Humans; Live | 2013 |
High Dose Oral Furosemide with Salt Ingestion in the Treatment of Refractory Ascites of Liver Cirrhosis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Albumins; Ascites; Bilirubin; Creatinine; End | 2016 |
Clinical Trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites.
Topics: Adult; Aged; Aged, 80 and over; Ascites; Diuretics; Dose-Response Relationship, Drug; Female; Furose | 2009 |
Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial.
Topics: Adult; Aged; Ascites; Canrenoic Acid; Diuretics; Dose-Response Relationship, Drug; Drug Administrati | 2010 |
Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial.
Topics: Adult; Aged; Ascites; Canrenoic Acid; Diuretics; Dose-Response Relationship, Drug; Drug Administrati | 2010 |
Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial.
Topics: Adult; Aged; Ascites; Canrenoic Acid; Diuretics; Dose-Response Relationship, Drug; Drug Administrati | 2010 |
Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial.
Topics: Adult; Aged; Ascites; Canrenoic Acid; Diuretics; Dose-Response Relationship, Drug; Drug Administrati | 2010 |
Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia--a randomized, double-blind, placebo-controlled study.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Ascites; Body Weight; Diuretics; Double-Blind Metho | 2010 |
A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis.
Topics: Administration, Oral; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Body Weight; | 2010 |
The effects of midodrine on the natriuretic response to furosemide in cirrhotics with ascites.
Topics: Administration, Oral; Ascites; Creatinine; Cross-Over Studies; Diuretics; Double-Blind Method; Femal | 2010 |
Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial.
Topics: Adult; Aged; Ascites; Bed Rest; Diuretics; Exercise; Female; Furosemide; Humans; Liver Cirrhosis; Ma | 2003 |
Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety.
Topics: Aged; Ascites; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Liver Cirrhosis; Ma | 2003 |
Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety.
Topics: Aged; Ascites; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Liver Cirrhosis; Ma | 2003 |
Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety.
Topics: Aged; Ascites; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Liver Cirrhosis; Ma | 2003 |
Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety.
Topics: Aged; Ascites; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Liver Cirrhosis; Ma | 2003 |
Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis.
Topics: Aged; Arachidonic Acid; Dietary Supplements; Diuretics; Double-Blind Method; Fatty Acids; Female; Fu | 2004 |
Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites.
Topics: Ascites; Celecoxib; Dinoprostone; Double-Blind Method; Female; Furosemide; Glomerular Filtration Rat | 2005 |
The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.
Topics: Adult; Aged; Aldosterone; Ascites; Diuretics; Drug Therapy, Combination; Female; Furosemide; Gastroi | 2006 |
Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study.
Topics: Administration, Oral; Adult; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Ascite | 2006 |
Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system.
Topics: Angiotensins; Ascites; Clonidine; Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Ra | 2006 |
The changes in renal function after a single dose of intravenous furosemide in patients with compensated liver cirrhosis.
Topics: Aged; Biological Transport; Creatinine; Diuretics; Dose-Response Relationship, Drug; Female; Furosem | 2006 |
Studies on furosemide: an effective oral saludiuretic for bilharzial ascites.
Topics: Adolescent; Adult; Ascites; Body Weight; Female; Furosemide; Humans; Liver Cirrhosis; Male; Middle A | 1967 |
Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.
Topics: Ascites; Clinical Trials as Topic; Diuresis; Dose-Response Relationship, Drug; Furosemide; Humans; L | 1983 |
Comparison of six treatments of ascites in patients with liver cirrhosis. A clinical trial.
Topics: Amiloride; Ascites; Blood Chemical Analysis; Clinical Trials as Topic; Diet, Sodium-Restricted; Diur | 1983 |
Use of diuretics in the treatment of cirrhotic ascites.
Topics: Ascites; Bumetanide; Diuresis; Diuretics; Dose-Response Relationship, Drug; Furosemide; Humans; Kidn | 1983 |
Diuresis in the ascitic patient: a randomized controlled trial of three regimens.
Topics: Ascites; Body Weight; Clinical Trials as Topic; Drug Therapy, Combination; Female; Furosemide; Hepat | 1981 |
Effectiveness of ibopamine in the management of ascitic liver cirrhosis--a controlled study v placebo and frusemide.
Topics: Adult; Aged; Clinical Trials as Topic; Deoxyepinephrine; Diuresis; Diuretics; Dopamine; Female; Furo | 1981 |
Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function.
Topics: Adrenergic alpha-Antagonists; Aldosterone; Blood Pressure; Female; Furosemide; Glomerular Filtration | 1995 |
Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide.
Topics: Ascites; Diuretics; Drug Administration Schedule; Drug Therapy, Combination; Female; Furosemide; Hum | 1994 |
Effects of imidazole-salicylate on renal function and the diuretic action of furosemide in cirrhotic patients with ascites.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Ascites; Blood Platelets; Diuretics; Double-Bl | 1993 |
Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites. A randomized, double blind cross-over trial.
Topics: Adult; Aged; Ascites; Diuretics; Double-Blind Method; Female; Furosemide; Humans; Liver Cirrhosis; M | 1993 |
Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content.
Topics: Ascites; Canrenoic Acid; Diet, Sodium-Restricted; Female; Furosemide; Humans; Liver Cirrhosis; Male; | 1993 |
Torasemide versus furosemide in cirrhosis: a long-term, double-blind, randomized clinical study.
Topics: Ascites; Diuretics; Double-Blind Method; Drug Therapy, Combination; Furosemide; Humans; Liver Cirrho | 1993 |
Torasemide in the treatment of patients with cirrhosis and ascites.
Topics: Adult; Aged; Ascites; Body Weight; Canrenoic Acid; Combined Modality Therapy; Diet, Sodium-Restricte | 1993 |
Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites.
Topics: Adult; Aged; Ascites; Diuretics; Drug Resistance; Female; Furosemide; Gas Chromatography-Mass Spectr | 1996 |
Therapeutic effects of diuretics and paracentesis on lung function in patients with non-alcoholic cirrhosis and tense ascites.
Topics: Aged; Ascites; Diuretics; Furosemide; Humans; Liver Cirrhosis; Lung; Male; Middle Aged; Paracentesis | 1997 |
[Comparison between torasemide and furosemide in the treatment of ascites in cirrhotic patients].
Topics: Ascites; Diuretics; Female; Furosemide; Humans; Liver Cirrhosis; Male; Middle Aged; Sulfonamides; To | 1997 |
[Analysis of the curative effect on ascites in liver cirrhosis by integrated traditional Chinese and Western medicine].
Topics: Adult; Aged; Diuretics; Dopamine; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Furosemi | 1997 |
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial.
Topics: Adult; Aged; Ascites; Bed Rest; Bilirubin; Blood Pressure; Blood Urea Nitrogen; Canrenoic Acid; Comb | 1999 |
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial.
Topics: Adult; Aged; Ascites; Bed Rest; Bilirubin; Blood Pressure; Blood Urea Nitrogen; Canrenoic Acid; Comb | 1999 |
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial.
Topics: Adult; Aged; Ascites; Bed Rest; Bilirubin; Blood Pressure; Blood Urea Nitrogen; Canrenoic Acid; Comb | 1999 |
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial.
Topics: Adult; Aged; Ascites; Bed Rest; Bilirubin; Blood Pressure; Blood Urea Nitrogen; Canrenoic Acid; Comb | 1999 |
Long-term efficacy of torsemide compared with frusemide in cirrhotic patients with ascites.
Topics: Adult; Aged; Analysis of Variance; Ascites; Chi-Square Distribution; Diuretics; Drug Administration | 2001 |
Effect of albumin-furosemide mixtures on response to furosemide in cirrhotic patients with ascites.
Topics: Adult; Albumins; Ascites; Cross-Over Studies; Diuretics; Female; Furosemide; Humans; Liver Cirrhosis | 2001 |
An optimal diuretic regimen for cirrhotic ascites. A controlled trial evaluating safety and efficacy of spironolactone and furosemide.
Topics: Ascites; Body Weight; Clinical Trials as Topic; Diuretics; Furosemide; Humans; Liver Cirrhosis; Plas | 1977 |
Effect of triamterene on potassium excretion in cirrhotic patients receiving furosemide.
Topics: Chlorides; Clinical Trials as Topic; Drug Therapy, Combination; Electrolytes; Female; Furosemide; Hu | 1977 |
[Clinical evaluation of the use of diuretics in the ascitic phase of hepatic cirrhosis].
Topics: Acute Disease; Adult; Aged; Amiloride; Ascites; Clinical Trials as Topic; Diuretics; Drug Evaluation | 1977 |
[Letter: Ascrtogenicliver cirrhosis. Effect of amiloride on water-electrolytemetabolsim].
Topics: Amiloride; Ascites; Chlorides; Clinical Trials as Topic; Furosemide; Humans; Hydrochlorothiazide; Hy | 1975 |
Large volume paracentesis and intravenous dextran to treat tense ascites.
Topics: Adult; Ascites; Combined Modality Therapy; Dextrans; Drainage; Drug Administration Schedule; Female; | 1992 |
[Treatment of ascites in patients with liver cirrhosis without neither hyponatremia nor renal insufficiency. Results of a randomized study comparing diuretics and punctures compensated by albumin].
Topics: Aged; Albumins; Ascites; Combined Modality Therapy; Drug Therapy, Combination; Female; Furosemide; H | 1992 |
Effect of propranolol on urinary prostaglandin E2 excretion and renal interlobar arterial blood flow after furosemide administration in patients with hepatic cirrhosis.
Topics: Adult; Dinoprostone; Drug Interactions; Female; Furosemide; Humans; Liver Cirrhosis; Male; Middle Ag | 1992 |
Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study.
Topics: Ascites; Diuretics; Double-Blind Method; Furosemide; Humans; Liver Cirrhosis; Sulfonamides; Torsemid | 1991 |
Prediction of diuretic mobilization of cirrhotic ascites by pretreatment fractional sodium excretion.
Topics: Adult; Aged; Ascites; Creatinine; Diuretics; Drug Therapy, Combination; Female; Furosemide; Glomerul | 1990 |
Paracentesis versus diuretics in the treatment of cirrhotics with tense ascites.
Topics: Ascites; Clinical Trials as Topic; Diuretics; Female; Follow-Up Studies; Furosemide; Humans; Liver C | 1985 |
Comparison of diuretic effects and pharmacokinetics of torasemide and furosemide after a single oral dose in patients with hydropically decompensated cirrhosis of the liver.
Topics: Administration, Oral; Body Weight; Clinical Trials as Topic; Diuresis; Diuretics; Double-Blind Metho | 1988 |
Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study.
Topics: Albumins; Ascites; Clinical Trials as Topic; Diuretics; Drainage; Female; Follow-Up Studies; Furosem | 1987 |
Comparative pharmacodynamics of furosemide and muzolimine in cirrhosis. Study on renal sodium and potassium handling and renin-aldosterone axis.
Topics: Angiotensin II; Diuresis; Furosemide; Glomerular Filtration Rate; Humans; Liver Cirrhosis; Male; Mid | 1985 |
Sulindac and indomethacin suppress the diuretic action of furosemide in patients with cirrhosis and ascites: evidence that sulindac affects renal prostaglandins.
Topics: Anti-Inflammatory Agents; Ascites; Clinical Trials as Topic; Creatinine; Dinoprostone; Diuresis; Dru | 1985 |
Spironolactone and frusemide in cirrhosis with ascites.
Topics: Adolescent; Adult; Body Weight; Clinical Trials as Topic; Diuresis; Drug Synergism; Female; Furosemi | 1973 |
Renal function in cirrhosis and the effects of prostaglandin A.
Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Furosemide; Glomerular Filtration Rate; | 1974 |
Clinical trial of a new diuretic, bumetanide, in seriously ill patients.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Benzoates; Butylamines; Clinical Trials as Topic; Diur | 1974 |
A controlled clinical trial comparing the diuretic furosemide and hydrochlorothiazide.
Topics: Clinical Trials as Topic; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; Liver Cirrhosis; N | 1968 |
[Biometric assay of the saluretic synergism of clopamide and furosemide].
Topics: Adult; Aged; Amides; Aortic Valve Insufficiency; Biometry; Clinical Trials as Topic; Clopamide; Diur | 1969 |
[Amiloride. A clinical study of a potassium-retaining diuretic].
Topics: Adult; Aged; Bendroflumethiazide; Bicarbonates; Clinical Trials as Topic; Diuresis; Diuretics; Femal | 1969 |
High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronism.
Topics: Adult; Aged; Body Weight; Chlorides; Clinical Trials as Topic; Clopamide; Creatinine; Diet, Sodium-R | 1970 |
[Controlled clinical trial of the association of furosemide and triamterene].
Topics: Ascites; Diuresis; Edema; Electrolytes; Furosemide; Heart Failure; Humans; Liver Cirrhosis; Triamter | 1971 |
[Clinical evaluation of a new diuretic].
Topics: Clinical Trials as Topic; Diuretics; Furosemide; Heart Failure; Humans; Hypertension; Liver Cirrhosi | 1965 |
[Modern diuretic therapy in chronic liver diseases].
Topics: Adult; Aged; Ascites; Clinical Trials as Topic; Diuretics; Female; Furosemide; Humans; Hydrochloroth | 1965 |
Therapy with combinations of diuretic agents: comparative studies.
Topics: Acetazolamide; Acid-Base Equilibrium; Aged; Clinical Trials as Topic; Drug Synergism; Furosemide; Hu | 1966 |
184 other studies available for furosemide and Cirrhosis, Liver
| Article | Year |
|---|---|
A 50-Year-Old Woman With Shortness of Breath.
Topics: Azygos Vein; Diuretics; Dyspnea; Esophageal and Gastric Varices; Female; Furosemide; Hepatitis C; Hu | 2021 |
Effects of adding hypertonic saline solutions and/or etilefrine to standard diuretics therapy in cirrhotic patients with ascites.
Topics: Aldosterone; Ascites; Biomarkers; C-Reactive Protein; Creatinine; Diuretics; Etilefrine; Furosemide; | 2022 |
Novel Explanted Human Liver Model to Assess Hepatic Extraction, Biliary Excretion and Transporter Function.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Digoxin; Drug Interactions; Furosemide; Hep | 2023 |
Management of refractory ascites attenuates muscle mass reduction and improves survival in patients with decompensated cirrhosis.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ascites; Diuretics; Femal | 2020 |
Finger clubbing and cirrhosis in a sarcoidosis patient.
Topics: Administration, Oral; Anti-Inflammatory Agents; Ascites; Diuretics; Female; Furosemide; Humans; Hype | 2019 |
Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema.
Topics: Adult; Aged; Aged, 80 and over; Diuretics; Drug Therapy, Combination; Edema; Female; Furosemide; Hum | 2020 |
Potentially inappropriate use of furosemide in a very elderly population: An observational study.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitor | 2017 |
Possible gasoline-induced chronic liver injury due to occupational malpractice in a motor mechanic: a case report.
Topics: Automobiles; Cholagogues and Choleretics; Directive Counseling; Diuretics; Furosemide; Gasoline; Gas | 2017 |
Positive Response to Tolvaptan Treatment Would Be a Good Prognostic Factor for Cirrhotic Patients with Ascites.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Ascites; Female; Furosemide; Humans; Kaplan-Meier E | 2019 |
Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Drug Therapy, Combination; | 2019 |
Cell-free and Concentrated Ascites Reinfusion Therapy for Refractory Ascites in Cirrhosis in Post-marketing Surveillance and the Role of Tolvaptan.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ascites; Ascitic Fluid; Diuretic | 2019 |
Effect of furosemide on muscle cramps in patients with liver cirrhosis.
Topics: Aged; Diuretics; Female; Furosemide; Humans; Liver Cirrhosis; Male; Middle Aged; Muscle Cramp; Risk | 2020 |
Re-response to tolvaptan after furosemide dose reduction in a patient with refractory ascites.
Topics: Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Diuretics; Drug Administration Sch | 2015 |
Red blood cell sodium transport in patients with cirrhosis.
Topics: Adult; Aged; Biological Transport; Case-Control Studies; Enzyme Inhibitors; Erythrocytes; Female; Fu | 2016 |
Cirrhosis complications: keeping them under control.
Topics: Antihypertensive Agents; Ascites; Diuretics; Furosemide; Hemorrhage; Hepatic Encephalopathy; Humans; | 2015 |
Immune-Inflammatory and Metabolic Effects of High Dose Furosemide plus Hypertonic Saline Solution (HSS) Treatment in Cirrhotic Subjects with Refractory Ascites.
Topics: Administration, Intravenous; Aged; Ascites; Biomarkers; Cytokines; Diuretics; Female; Furosemide; Hu | 2016 |
Liver: diuretic agents for ascites: joining forces from the start?
Topics: Ascites; Canrenoic Acid; Drug Therapy, Combination; Furosemide; Humans; Liver Cirrhosis; Mineralocor | 2010 |
Oral furosemide-induced natriuresis: a potential method for identifying cirrhotic patients with refractory ascites.
Topics: Administration, Oral; Ascites; Diuretics; Furosemide; Hepatorenal Syndrome; Humans; Infusions, Intra | 2010 |
Refractory ascites: can it be defined only by the response to furosemide and spironolactone?
Topics: Ascites; Diuretics; Furosemide; Glomerular Filtration Rate; Hepatorenal Syndrome; Humans; Liver Cirr | 2010 |
Liver fibrosis impairs hepatic pharmacokinetics of liver transplant drugs in the rat model.
Topics: Animals; Bile Ducts, Intrahepatic; Carbon Tetrachloride; Extracellular Space; Furosemide; Liver; Liv | 2010 |
Midodrine and furosemide-induced natriuresis in cirrhotics with ascites.
Topics: Ascites; Furosemide; Humans; Liver Cirrhosis; Midodrine; Natriuresis | 2011 |
An unusual case of stroke.
Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diuretics; Female; Furo | 2012 |
[CLINICO-THERAPEUTIC OBSERVATIONS AND RENAL FUNCTION TESTS WITH THE NEW DIURETIC, FUROSEMIDE].
Topics: Diuretics; Edema; Furosemide; Heart Diseases; Heart Failure; Hepatitis; Hypertension; Kidney Functio | 1964 |
A NEW EFFECTIVE DIURETIC--LASIX.
Topics: Chlorthalidone; Diuretics; Drug Therapy; Furosemide; Heart Failure; Hydrochlorothiazide; Hypokalemia | 1964 |
THE DIURETIC RESPONSE TO FRUSEMIDE.
Topics: Chlorides; Diuretics; Fluids and Secretions; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; | 1964 |
[USE OF FUROSEMIDE (LASIX) IN GERIATRICS. CONTRIBUTION TO THE EVALUATION OF THE SO-CALLED DIABETOGENIC EFFECT OF SALIDIURETICS].
Topics: Diabetes Mellitus; Diuretics; Drug Therapy; Edema; Furosemide; Geriatrics; Hypertension; Liver Cirrh | 1965 |
EXPERIENCES WITH FUROSEMIDE IN RENAL DISEASE.
Topics: Biomedical Research; Blood Urea Nitrogen; Creatine; Creatinine; Diabetic Nephropathies; Diuretics; D | 1965 |
[EXPERIENCES WITH FUROSEMIDE (LASIX) IN EDEMA OF VARIOUS ORIGINS].
Topics: Diabetes Mellitus; Diuretics; Edema; Furosemide; Heart Failure; Humans; Liver Cirrhosis | 1965 |
EFFECT OF A NEW ORAL DIURETIC--FURSEMIDE ON BILHARZIAL CIRRHOSIS WITH ASCITES.
Topics: Animals; Ascites; Diuretics; Drug Therapy; Furosemide; Humans; Liver Cirrhosis; Schistosoma; Schisto | 1964 |
[DRUG TREATMENT OF LIVER CIRRHOSIS].
Topics: Diuretics; Drug Therapy; Ethacrynic Acid; Furosemide; Humans; Liver Cirrhosis; Triamterene | 1965 |
[CLINICAL EXPERIENCES WITH THE NEW DIURETIC, FURSEMID].
Topics: Diuretics; Drug Therapy; Edema; Furosemide; Heart Failure; Humans; Liver Cirrhosis | 1964 |
[EXPERIENCES WITH THE USE OF FUROSEMIDE IN THE HOSPITAL].
Topics: Diuretics; Furosemide; Heart Diseases; Humans; Liver Cirrhosis | 1965 |
[CLINICAL EXPERIMENTATION WITH A NEW DIURETIC: 4-CHLORO-N-(2-FURFURYLMETHYL)-5-SULFAMOYLANTHRANILIC ACID (FUROSEMIDE)].
Topics: Diuretics; Furosemide; Heart Diseases; Humans; Liver Cirrhosis; Research Design | 1965 |
[FIRST FINDINGS ON THE DIURETIC ACTIVITY OF A NEW SULFAMIDE DERIVATIVE (FUROSEMIDE) IN AGED].
Topics: Diuretics; Furosemide; Geriatrics; Heart Diseases; Humans; Liver Cirrhosis; Pulmonary Edema | 1965 |
[DIURETIC THERAPY WITH FUROSEMIDE (LASIX)].
Topics: Diuretics; Furosemide; Heart Diseases; Humans; Liver Cirrhosis | 1965 |
FUROSEMIDE (LASIX) AS A DIURETIC.
Topics: Chlorothiazide; Chlorthalidone; Diuretics; Drug Therapy; Furosemide; Heart Failure; Hydrochlorothiaz | 1965 |
[CLINICAL EXPERIENCES WITH A NEW NON-MERCURIAL DIURETIC: 4-CHLORO-N-(2-FURYL-METHYL)-5-SULFAMYL-ANTHRANILIC ACID OR FUROSEMIDE].
Topics: Ascites; Diuretics; Edema; Furosemide; Heart Diseases; Humans; Liver Cirrhosis; ortho-Aminobenzoates | 1965 |
[CLINICAL RESEARCH ON THE USE OF 4-CHLORO-N-(2-FURYLMETHYL)-5-SULFAMYL-ANTHRANILIC ACID].
Topics: Ascites; Diuretics; Edema; Furosemide; Heart Failure; Humans; Liver Cirrhosis; ortho-Aminobenzoates | 1965 |
[The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
Topics: Adult; Aged; Ascites; Diuretics; Female; Furosemide; Humans; Infusions, Intravenous; Liver Cirrhosis | 2003 |
[Mechanism of action of xipamide and its classification as a "low ceiling diuretic". Pharmacodynamic-pharmacokinetic studies in healthy volunteers and in kidney and liver patients].
Topics: Bilirubin; Cholestasis; Creatinine; Diet, Sodium-Restricted; Diuresis; Diuretics; Furosemide; Glomer | 2005 |
Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
Topics: Adult; Aged; Chylous Ascites; Diuretics; Drug Therapy, Combination; Female; Furosemide; Gastrointest | 2005 |
The significance of the furosemide test for predicting ascites control by diuretics in cirrhotics: a comparison with volume expansion and octreotide infusion.
Topics: Aged; Ascites; Diuretics; Female; Furosemide; Gastrointestinal Agents; Glomerular Filtration Rate; H | 2006 |
Pharmacologic approaches for volume excess in acute kidney injury (AKI).
Topics: Acute Kidney Injury; Ascites; Bumetanide; Diuretics; Fluid Therapy; Furosemide; Heart Failure; Hepat | 2008 |
Furosemide, a new diuretic in edematous states. Clinical studies in patients with congestive heart failure and cirrhosis of the liver.
Topics: Aged; Body Weight; Edema; Female; Furosemide; Heart Failure; Humans; Hypokalemia; Injections, Intrav | 1967 |
Lasix.
Topics: Diuresis; Edema; Furosemide; Heart Failure; Humans; Kidney Diseases; Liver Cirrhosis; Potassium Defi | 1967 |
Clinical evaluation of furosemide.
Topics: Adult; Aged; Edema; Female; Furosemide; Heart Failure; Humans; Hypertension; Liver Cirrhosis; Male; | 1967 |
[Observations on the diuretic activity of furosemide].
Topics: Diuresis; Edema; Furosemide; Heart Diseases; Heart Failure; Humans; Liver Cirrhosis; Water-Electroly | 1967 |
[The behavior of uricemia during treatment with spironolactone and with other diuretics].
Topics: Acetazolamide; Adolescent; Adult; Aged; Chlorthalidone; Clopamide; Diuretics; Ethacrynic Acid; Femal | 1967 |
[Observations on a case of liver cirrhosis in its terminal phase].
Topics: Ascites; Bilirubin; Blood Glucose; Furosemide; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; | 1984 |
Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites.
Topics: Aspirin; Diuresis; Furosemide; Glomerular Filtration Rate; Humans; Kidney; Liver Cirrhosis; Liver Ci | 1983 |
Colchicine therapy for hepatic fibrosis in a dog.
Topics: Animals; Biopsy; Colchicine; Dog Diseases; Dogs; Female; Furosemide; Liver; Liver Cirrhosis | 1984 |
Propranolol in the treatment of cirrhotic ascites.
Topics: Ascites; Furosemide; Humans; Liver Cirrhosis; Natriuresis; Propranolol; Triamterene | 1984 |
Clinical pharmacokinetics and diuretic effect of furosemide in plain tablet and retard capsule with normal subjects and cirrhotic patients.
Topics: Adult; Delayed-Action Preparations; Diuretics; Furosemide; Humans; Hydrogen-Ion Concentration; Kinet | 1983 |
Quantitative determination of furosemide in plasma, plasma water, urine and ascites fluid by high-performance liquid chromatography.
Topics: Ascitic Fluid; Blood Proteins; Chromatography, High Pressure Liquid; Furosemide; Humans; Kidney Dise | 1984 |
A furosemide test in the functional evaluation of the human nephron in vivo.
Topics: Body Water; Cell Membrane Permeability; Furosemide; Glomerular Filtration Rate; Humans; Kidney Failu | 1983 |
An intensive drug monitoring study suggesting possible clinical irrelevance of impaired drug disposition in liver disease.
Topics: Brain Diseases; Diuretics; Drug Evaluation; Drug-Related Side Effects and Adverse Reactions; Furosem | 1983 |
Acute effects of saralasin on plasma aldosterone in different pathophysiological conditions.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Bartter Syndrome; Child; Diet, Sodium-Restricted; Fe | 1980 |
Furosemide disposition in cirrhosis.
Topics: Adult; Creatinine; Furosemide; Humans; Kinetics; Liver Cirrhosis; Male; Middle Aged; Models, Biologi | 1982 |
Pharmacokinetics of furosemide in patients with hepatic cirrhosis.
Topics: Adult; Aged; Ascites; Diuresis; Female; Furosemide; Humans; Kinetics; Liver Cirrhosis; Male; Middle | 1982 |
[Treatment of irreducible ascites of cirrhotic patients with peritoneo-jugular shunt].
Topics: Ascites; Breathing Exercises; Diet, Sodium-Restricted; Female; Furosemide; Humans; Jugular Veins; Li | 1982 |
Comparison of azosemide and furosemide in ascitic patients without and during administration of spironolactone.
Topics: Administration, Oral; Adult; Aged; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; | 1982 |
[Clinical program of therapy for ascitic edema in liver disease].
Topics: Ascites; Diuresis; Edema; Furosemide; Humans; Liver Cirrhosis | 1982 |
Furosemide kinetics in patients with hepatic cirrhosis with ascites.
Topics: Adult; Aged; Ascites; Diuresis; Furosemide; Humans; Kinetics; Liver Cirrhosis; Male; Middle Aged | 1981 |
[Clinical evaluation of bumetanide in the diuretic treatment of heart failure and liver cirrhosis].
Topics: Adult; Aged; Bumetanide; Diuresis; Diuretics; Electrolytes; Ethacrynic Acid; Female; Furosemide; Hea | 1981 |
Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide.
Topics: Adult; Diuresis; Electrolytes; Female; Furosemide; Humans; Kidney Failure, Chronic; Kinetics; Liver | 1981 |
Further investigations on the binding of loop diuretics to serum proteins from patients with liver disease.
Topics: Adult; Bilirubin; Blood Proteins; Bumetanide; Diuretics; Female; Furosemide; Hepatitis; Humans; Live | 1981 |
Treatment of hepatorenal syndrome.
Topics: Adult; Ascites; Ascitic Fluid; Creatine; Furosemide; Humans; Infusions, Parenteral; Kidney Diseases; | 1980 |
Ascites formation and dynamics in cirrhotic patients.
Topics: Ascites; Diuretics; Furosemide; Humans; Liver Cirrhosis | 1995 |
Ascites free-water dynamics in decompensated cirrhosis: effects of acute and chronic frusemide treatment.
Topics: Abdomen; Administration, Oral; Adult; Aged; Aged, 80 and over; Ascites; Body Water; Body Weight; Fem | 1995 |
Parathyroid hormone in blood pressure and volume homeostasis in healthy subjects, hyperparathyroidism, liver cirrhosis and glomerulonephritis. A possible interaction with angiotensin II and atrial natriuretic peptide.
Topics: Adolescent; Adult; Aged; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Blood Volume; Fe | 1994 |
Hemodynamic effects of acute administration of furosemide in patients with cirrhosis receiving beta-adrenergic antagonists.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Female; Furosemide; Hemodynamics; Humans; Hypertension, Po | 1994 |
The intraabdominal pressure in decompensated cirrhosis: relationship with ascites volume and turn-over.
Topics: Adult; Aged; Aged, 80 and over; Ascites; Female; Furosemide; Humans; Hydrostatic Pressure; Liver Cir | 1994 |
Hyperkalemia due to hyporeninemic hypoaldosteronism with liver cirrhosis and hypertension.
Topics: Aldosterone; Captopril; Furosemide; Humans; Hyperkalemia; Hypertension; Hypoaldosteronism; Liver Cir | 1993 |
Lack of effect of cimetidine on furosemide kinetics and dynamics in patients with hepatic cirrhosis.
Topics: Adult; Aged; Cimetidine; Diuresis; Furosemide; Humans; Kidney; Liver Cirrhosis; Middle Aged; Sodium | 1993 |
Attenuation by spironolactone of the magnesiuric effect of acute frusemide administration in patients with liver cirrhosis and ascites.
Topics: Adult; Diuresis; Female; Furosemide; Humans; Liver Cirrhosis; Magnesium; Male; Middle Aged; Potassiu | 1993 |
Plasma volume contraction in portal hypertension.
Topics: Aged; Aldosterone; Blood Pressure; Dose-Response Relationship, Drug; Female; Furosemide; Hemodynamic | 1993 |
Concurrent use of phenytoin and furosemide: problems in a patient with congestive cardiac failure, chronic renal failure, liver cirrhosis and fluid overload.
Topics: Anticonvulsants; Diuretics; Drug Interactions; Drug Therapy, Combination; Furosemide; Heart Failure; | 1996 |
Sequential nephron blockade breaks resistance to diuretics in edematous states.
Topics: Acetazolamide; Adult; Ascites; Diuresis; Diuretics; Edema; Female; Furosemide; Heart Failure; Humans | 1997 |
Scenario number three: cardiopulmonary management.
Topics: Disease-Free Survival; Diuretics; Erythrocyte Transfusion; Furosemide; Humans; Liver Cirrhosis; Live | 1996 |
Intravenous albumin with diuretics: protean lessons to be learnt?
Topics: Ascites; Bed Rest; Canrenoic Acid; Diuretics; Furosemide; Humans; Infusions, Intravenous; Liver Cirr | 1999 |
Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites.
Topics: Ascites; Diuretics; Drug Resistance; Female; Furosemide; Humans; Liver Cirrhosis; Male; Middle Aged; | 2001 |
Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients.
Topics: Adult; Albumins; Ascites; Diuretics; Drug Resistance; Drug Therapy, Combination; Female; Furosemide; | 2001 |
[Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
Topics: Aldosterone; Ascites; Diuretics; Female; Furosemide; Glomerular Filtration Rate; Humans; Hyperkalemi | 2001 |
[Therapeutic program for ascites. Recommendations from the Swedish Society of Gastroenterology and Gastrointestinal Endoscopy].
Topics: Ascites; Contraindications; Diuretics; Furosemide; Humans; Liver Cirrhosis; Paracentesis; Peritoneov | 2001 |
Diuretic-induced renal impairment without volume depletion in cirrhosis: changes in the renin-angiotensin system and the effect of beta-adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Adult; Creatinine; Female; Furosemide; Humans; Kidney; Kidney Diseases; | 1979 |
The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites.
Topics: Adult; Aged; Aldosterone; Ascites; Body Weight; Budd-Chiari Syndrome; Cardiac Output; Diuresis; Drai | 1979 |
Furosemide, cirrhosis, and hypercalcemia.
Topics: Furosemide; Humans; Hypercalcemia; Liver Cirrhosis; Male; Middle Aged | 1979 |
[Iatrogenic ventricular tachycardia].
Topics: Adams-Stokes Syndrome; Aged; Angina Pectoris; Female; Furosemide; Humans; Lidoflazine; Liver Cirrhos | 1979 |
Influence of hepatic insufficiency in pharmacokinetics of drugs: example for an anthranilic diuretic.
Topics: Adult; Aged; Furosemide; Humans; Kinetics; Liver Cirrhosis; Liver Diseases; Middle Aged; Pharmaceuti | 1979 |
Potassium and magnesium depletion in patients with cirrhosis on maintenance diuretic regimens.
Topics: Drug Therapy, Combination; Furosemide; Humans; Leukocytes; Liver Cirrhosis; Magnesium; Potassium; Sp | 1977 |
[Renal toxicity of the association: gentamicin/furosemide. One case (author's transl)].
Topics: Adult; Drug Therapy, Combination; Furosemide; Gentamicins; Hepatitis B; Humans; Kidney Diseases; Liv | 1978 |
Mobilization of ascites in cirrhotic dogs following furosemide or mannitol diuresis.
Topics: Animals; Ascites; Central Venous Pressure; Dimethylnitrosamine; Diuresis; Dogs; Extracellular Space; | 1978 |
Frusemide in liver diseases with renal failure.
Topics: Acute Kidney Injury; Adult; Aged; Furosemide; Hepatitis A; Humans; Liver Cirrhosis; Liver Diseases; | 1978 |
[Furosemide in progressive doses. Its use in edematous states].
Topics: Diuresis; Drug Evaluation; Edema; Edema, Cardiac; Female; Furosemide; Humans; Liver Cirrhosis; Male; | 1978 |
Effect of metolazone addition on furosemide resistant cases of edema.
Topics: Adolescent; Adult; Diuretics; Drug Resistance; Drug Therapy, Combination; Edema; Female; Furosemide; | 1978 |
Furosemide-induced adverse reactions in cirrhosis of the liver.
Topics: Administration, Oral; Adult; Aged; Diuretics; Dose-Response Relationship, Drug; Drug Interactions; F | 1979 |
Improved method and its clinical application of a radioimmunoassay of arginine vasopressin in human serum.
Topics: Arginine Vasopressin; Diabetes Insipidus; Evaluation Studies as Topic; Furosemide; Humans; Liver Cir | 1977 |
Questionable value of furosemide in preventing renal failure.
Topics: Acute Kidney Injury; Adult; Furosemide; Glomerular Filtration Rate; Hemodynamics; Humans; Hypotensio | 1977 |
[The therapy of edematous diseases].
Topics: Antihypertensive Agents; Bed Rest; Diabetes Insipidus; Diuretics; Diuretics, Osmotic; Edema; Ethacry | 1977 |
[Aldosterone and renin in liver cirrhosis with ascites].
Topics: Aldosterone; Ascites; Furosemide; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Renin; Spiron | 1977 |
[Criteria for intensive treatment of hepatic coma].
Topics: Adult; Aged; Animals; Cholangitis; Ethacrynic Acid; Extracorporeal Circulation; Female; Furosemide; | 1976 |
[Therapeutic report on an injectable aldosterone antagonist (K-canrenoate) in states of water-salf retention].
Topics: Adult; Aged; Ascites; Canrenoic Acid; Drug Evaluation; Drug Therapy, Combination; Edema; Ethacrynic | 1976 |
[Systemic circulation in portal hypertension].
Topics: Blood Circulation; Blood Volume; Cardiac Output; Collateral Circulation; Furosemide; Hypertension, P | 1976 |
Clinical types and drug therapy of renal impairment in cirrhosis.
Topics: Acute Kidney Injury; Diagnosis, Differential; Diuretics; Furosemide; Humans; Kidney Diseases; Liver | 1975 |
[Portal hypertension from the internal medicine viewpoint].
Topics: Furosemide; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Spironolactone; Vasopressins | 1976 |
Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Captopril; Creatinine; Cyclic G | 1992 |
[Treatment of cirrhotic ascites].
Topics: Combined Modality Therapy; Diet, Sodium-Restricted; Diuretics; Drainage; Furosemide; Humans; Liver C | 1990 |
[A clinico-therapeutic study of the Bulgarian preparation fupiram].
Topics: Aged; Aged, 80 and over; Amiloride; Capsules; Diuresis; Drug Combinations; Drug Evaluation; Female; | 1991 |
Combined ascitic--fluid and furosemide infusion: a therapeutic option for massive diuretic-resistant ascites and severe oliguria of hepatic cirrhosis.
Topics: Adult; Ascites; Ascitic Fluid; Furosemide; Humans; Injections, Intraperitoneal; Injections, Intraven | 1991 |
Ascitic fluid protein and cellular changes during diuretic therapy in cirrhosis of liver.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ascitic Fluid; Blood Proteins; Cell Count; Furosemide; H | 1991 |
Atrial natriuretic factor, cyclic 3',5'-guanosine monophosphate and prostaglandin E2 in liver cirrhosis: relation to blood volume and changes in blood volume after furosemide.
Topics: Adult; Aged; Ascites; Atrial Natriuretic Factor; Blood Volume; Cyclic GMP; Dinoprostone; Diuresis; F | 1990 |
Reduction in hepatic venous pressure gradient as a consequence of volume contraction due to chronic administration of spironolactone in patients with cirrhosis and no ascites.
Topics: Adult; Aged; Blood Volume; Female; Furosemide; Hemodynamics; Humans; Liver Circulation; Liver Cirrho | 1991 |
Renal prostacyclin influences renal function in non-azotemic cirrhotic patients treated with furosemide.
Topics: 6-Ketoprostaglandin F1 alpha; Dinoprostone; Epoprostenol; Female; Furosemide; Humans; Kidney; Liver | 1991 |
[Pharmacokinetics and pharmacodynamics of furosemide in liver cirrhosis].
Topics: Furosemide; Hemodynamics; Humans; Kidney; Liver Cirrhosis | 1990 |
[Hepatic cirrhosis with refractory ascitis and changes in renal function: effects of the infusion of fresh plasma and furosemide].
Topics: Ascites; Female; Furosemide; Humans; Infusions, Intravenous; Kidney; Liver Cirrhosis; Male; Plasma | 1989 |
[Effect of furosemide on the renal prostaglandin system in liver cirrhosis with ascites].
Topics: Adult; Ascites; Circadian Rhythm; Dinoprost; Dinoprostone; Diuresis; Female; Furosemide; Humans; Kid | 1989 |
[Effect of captopril therapy on sodium and water excretion in patients with liver cirrhosis and ascites].
Topics: Adult; Aged; Ascites; Blood Pressure; Captopril; Diuresis; Diuretics; Dose-Response Relationship, Dr | 1989 |
A lithium clearance study of sodium reabsorption at the proximal tubule in liver cirrhosis with ascites.
Topics: Absorption; Ascites; Creatinine; Female; Furosemide; Humans; Kidney Tubules, Proximal; Lithium; Live | 1989 |
Reduction of portal pressure by acute administration of furosemide in patients with alcoholic cirrhosis.
Topics: Adult; Aged; Blood Circulation; Blood Pressure; Female; Furosemide; Humans; Hypertension; Liver Cirr | 1989 |
Role of diuretics, hormonal derangements, and clinical setting of hyponatremia in medical patients.
Topics: Aldosterone; Arginine Vasopressin; Diuretics; Electrolytes; Epinephrine; Furosemide; Heart Failure; | 1988 |
[Use of repeat courses of unithiol in the complex treatment of liver cirrhosis].
Topics: Adult; Dimercaprol; Drug Administration Schedule; Drug Therapy, Combination; Female; Furosemide; Hum | 1986 |
[Plasma renin substrate in normal subjects and various diseases--influence of sodium chloride and various medicines].
Topics: Adult; Aged; Angiotensinogen; Captopril; Cushing Syndrome; Female; Furosemide; Humans; Hyperaldoster | 1987 |
Ascites kinetics in cirrhosis: effects of rapid volume expansion and diuretic administration.
Topics: Albumins; Ascites; Ascitic Fluid; Diuresis; Furosemide; Humans; Kinetics; Liver Cirrhosis; Plasma Vo | 1988 |
Kinetics and dynamics of triamterene at steady-state in patients with cirrhosis.
Topics: Adult; Diuresis; Drug Therapy, Combination; Female; Furosemide; Humans; Liver Cirrhosis; Male; Middl | 1988 |
Combined use of water immersion and frusemide in treatment of resistant ascites in liver cirrhosis.
Topics: Adult; Ascites; Combined Modality Therapy; Furosemide; Humans; Immersion; Liver Cirrhosis; Male | 1987 |
The use of peritoneovenous shunting in unravelling the pathogenesis of ascites in cirrhosis.
Topics: Aldosterone; Ascites; Creatinine; Furosemide; Humans; Kidney; Liver Cirrhosis; Natriuresis; p-Aminoh | 1986 |
Refractory ascites: definition and mechanism.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Ascites; Diet, Sodium-Restricted; Diuretics; Drainage; Drug | 1987 |
Furosemide kinetics and dynamics in patients with cirrhosis.
Topics: Adult; Ascites; Biological Availability; Diuresis; Furosemide; Half-Life; Humans; Injections, Intrav | 1986 |
[Reasons for diuretic therapy of cirrhotic ascites].
Topics: Ascites; Bed Rest; Benzothiadiazines; Diet, Sodium-Restricted; Diuretics; Drug Therapy, Combination; | 1985 |
Pharmacokinetics and pharmacodynamic effects of furosemide in patients with liver cirrhosis.
Topics: Adult; Diuresis; Furosemide; Humans; Liver Cirrhosis; Metabolic Clearance Rate; Middle Aged; Water-E | 1985 |
Letter: Treatment of ascites.
Topics: Adult; Aged; Ascites; Ascitic Fluid; Diuresis; Furosemide; Humans; Infusions, Parenteral; Injections | 1974 |
Complications of diuretic therapy in hepatic cirrhosis.
Topics: Chlorothiazide; Diuretics; Ethacrynic Acid; Furosemide; Hepatic Encephalopathy; Humans; Hypokalemia; | 1966 |
Amiloride ('MK 870') in patients with ascites due to cirrhosis of the liver.
Topics: Adult; Ascites; Bicarbonates; Creatinine; Diuretics; Ethacrynic Acid; Furosemide; Guanidines; Humans | 1968 |
[Clinical study of amiloride hydrochloride, a diuretic with low potassium loss].
Topics: Arrhythmias, Cardiac; Blood Urea Nitrogen; Cardiac Complexes, Premature; Diuretics; Drug Synergism; | 1970 |
A new approach for refractory oedema--pharmacological paracentesis.
Topics: Ascites; Drug Administration Schedule; Edema; Electrolytes; Furosemide; Humans; Hypertension, Portal | 1973 |
Effects of furosemide uring antidiuresis and antinatriuresis induced by angiotensin.
Topics: Angiotensin II; Diuresis; Furosemide; Glomerular Filtration Rate; Humans; Iodine Isotopes; Kidney; L | 1967 |
[Disorders of water-electrolyte metabolism associated with decompensated cirrhosis. The danger of various therapeutic drugs].
Topics: Acute Kidney Injury; Adult; Aged; Ascites; Blood Transfusion; Blood Urea Nitrogen; Blood Volume Dete | 1968 |
[The salidiuretic interaction of angiotensin II and furosemide in ascitogenic hepatic cirrhosis].
Topics: Angiotensin II; Ascites; Diuresis; Drug Interactions; Electrolytes; Female; Furosemide; Humans; Kidn | 1969 |
Response of plasma aldosterone to postural change, diuretica, angiotensin II, sodium restriction or loading and prostaglandin.
Topics: Adrenocortical Hyperfunction; Aldosterone; Angiotensin II; Ascites; Cushing Syndrome; Diet; Diet, So | 1973 |
Pharmacokinetics of furosemide in advanced renal failure.
Topics: Administration, Oral; Creatinine; Dehydration; Furosemide; Half-Life; Humans; Injections, Intravenou | 1974 |
[Acute hemolysis in morbus Wilson (author's transl)].
Topics: Adolescent; Adult; Anemia, Hemolytic; Ascites; Bilirubin; Blood Coagulation Tests; Blood Protein Ele | 1974 |
[My prescription of diuretics].
Topics: Adolescent; Aged; Ascites; Diuretics; Edema, Cardiac; Female; Furosemide; Heart Failure; Humans; Kid | 1974 |
[Therapy of liver cirrhosis].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Diet, Sodium-Restricted; Esophageal and Gastric V | 1972 |
Electrocardiographic changes in hypomagnesemia.
Topics: Electrocardiography; Furosemide; Humans; Liver Cirrhosis; Magnesium; Magnesium Deficiency; Magnesium | 1972 |
[Comparison of the effectiveness and mechanism of action of the saluretic preparations triamterene and hypothiazide and their combination (triampur) in circulatory insufficiency].
Topics: Acid-Base Equilibrium; Adult; Aged; Arteriosclerosis; Circadian Rhythm; Coronary Disease; Creatinine | 1973 |
Use of a new diuretic agent (metolazone) in patients with edema and ascites.
Topics: Ascites; Blood Urea Nitrogen; Creatinine; Diuretics; Edema; Furosemide; Humans; Injections, Intraven | 1973 |
[Effect of furosemide combined with reinfusion of ascitic fluid in hepatic cirrhosis with refractory ascites and changes in renal function].
Topics: Ascites; Ascitic Fluid; Evaluation Studies as Topic; Furosemide; Humans; Kidney Failure, Chronic; Ki | 1973 |
[Effect of complex therapy on the electrolyte metabolism in patients with chronic hepatitis and liver cirrhosis].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Chronic Disease; Female; Furosemide; Hepatitis; Hu | 1973 |
Iatrogenic hyperkalemic paralysis with electrocardiographic changes.
Topics: Bicarbonates; Calcium; Electrocardiography; Furosemide; Gluconates; Glucose; Heart; Humans; Hyperkal | 1974 |
[Pathogenesis and therapy of ascites in liver cirrhosis].
Topics: Acid-Base Equilibrium; Alkalosis; Ascites; Deficiency Diseases; Diet; Diuresis; Diuretics; Furosemid | 1966 |
[Importance of hyperammoniemia of the renal origin in the pathogenesis of hepatic coma released in cirrhotic patients by diuretics generating hypokaliemia].
Topics: Acetazolamide; Acid-Base Equilibrium; Alkalosis; Ammonia; Ascites; Chlorides; Chlorthalidone; Edema; | 1969 |
Hyperkalemic intermittent paralysis associated with spironolactone in a patient with cardiac cirrhosis.
Topics: Acetazolamide; Adult; Aldosterone; Ascites; Female; Furosemide; Heart Failure; Heart Valve Diseases; | 1968 |
High doses of spironolactone in the treatment of liver cirrhosis with ascites.
Topics: Adult; Aged; Ascites; Furosemide; Humans; Liver Cirrhosis; Male; Middle Aged; Prednisolone; Spironol | 1972 |
[Intensive saluresis in the treatment of refractory edema due to chronic liver disease].
Topics: Blood Proteins; Chronic Disease; Diuresis; Edema; Electrolytes; Furosemide; Humans; Liver Cirrhosis; | 1972 |
Generalized burning paresthesia due to intravenous furosemide.
Topics: Ascites; Furosemide; Humans; Injections, Intravenous; Liver Cirrhosis; Male; Middle Aged; Paresthesi | 1971 |
[Comparison of the effectiveness and mechanism of action of the saluretics lasix, ethacrynic acid, brinaldix and triamterene in congestive cardiac insufficiency].
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Coronary Disease; Diuretics; Ethacrynic Acid; Female; Fur | 1971 |
A case of coarctation of the aorta with liver cirrhosis.
Topics: Aortic Coarctation; Blood Pressure; Furosemide; Humans; Hypertension; Liver Cirrhosis; Male; Middle | 1971 |
The complications of diuretic therapy in patients with cirrhosis.
Topics: Alkalosis; Ascites; Blood Urea Nitrogen; Chlorothiazide; Ethacrynic Acid; Furosemide; Hepatic Enceph | 1966 |
[Clinical evaluation of a new diuretic: furosemide].
Topics: Diuretics; Furosemide; Heart Failure; Humans; Liver Cirrhosis; Nephrotic Syndrome | 1965 |
[Management of hepatic ascites using Fursemide].
Topics: Adult; Ascites; Female; Furosemide; Humans; Liver Cirrhosis; Male; Methods; Middle Aged | 1968 |
[Experience in the treatment of water-salt retentions in cirrhosis by the antialdosterone 11614 R.P].
Topics: 17-Hydroxycorticosteroids; Adult; Androstanes; Ascites; Diuresis; Edema; Female; Furosemide; Humans; | 1969 |
Combined ascitic-fluid and furosemide infusion in the management of ascites.
Topics: Adult; Aged; Ascites; Ascitic Fluid; Bilirubin; Blood Proteins; Blood Urea Nitrogen; Body Weight; Cr | 1970 |
[Modern diuretics in the treatment of ascites caused by hepatic cirrhosis].
Topics: Adult; Aged; Aldosterone; Ascites; Diuretics; Female; Furosemide; Humans; Hydrochlorothiazide; Liver | 1970 |
[Comparative study of the effectiveness of Lasix in the treatment of edema of various origins].
Topics: Adolescent; Adult; Aged; Child; Edema; Female; Furosemide; Heart Failure; Humans; Liver Cirrhosis; M | 1970 |
[Prevention and therapy of hepatic coma].
Topics: Aged; Amides; Ammonia; Aspartic Acid; Chlorothiazide; Clopamide; Depression, Chemical; Diuretics; Fe | 1970 |
[Strength and speed of action of intravenous furosemide in ascitogenic liver cirrhosis in a 20 mg. dose. Preliminary findings].
Topics: Diuresis; Furosemide; Humans; Liver Cirrhosis | 1967 |
Amiloride. A potassium-sparing natriuretic agent.
Topics: Acetazolamide; Aldosterone; Ammonia; Ascites; Bicarbonates; Blood Pressure; Chlorides; Chlorothiazid | 1968 |
Ethacrynic acid and furosemide.
Topics: Ethacrynic Acid; Furosemide; Heart Failure; Humans; Liver Cirrhosis; Nephrosis | 1968 |
[Urinary excretion of magnesium in patients with liver cirrhosis treated with oral diuretics. Its variation through vasopressin].
Topics: Adult; Ascites; Diuretics; Ethacrynic Acid; Furosemide; Humans; Liver Cirrhosis; Magnesium; Male; Th | 1968 |
[Effects of furosemide on diuresis and salt diuresis, blood electrolytes concentrations in various aspects of renal function in liver cirrhotic patients with ascites].
Topics: Ascites; Diuresis; Electrolytes; Furosemide; Humans; Kidney; Liver Cirrhosis; Sodium Chloride | 1968 |
[Use of soluble 6-methyl-prednisolone combined with furosemide in hepatic cirrhosis].
Topics: Aged; Drug Synergism; Female; Furosemide; Humans; Liver Cirrhosis; Male; Middle Aged; Prednisolone | 1968 |
Clinical experience with furosemide.
Topics: Adolescent; Adult; Aged; Ascites; Carbon Dioxide; Chlorides; Diabetes Complications; Diuresis; Edema | 1968 |
[Diuretics in cirrhosis. Accidents. Indications].
Topics: Adrenal Cortex Hormones; Alkalosis; Blood Urea Nitrogen; Blood Volume; Diuretics; Edema; Ethacrynic | 1969 |
The impact of diuretics on chronic liver disease.
Topics: Alcoholism; Ascites; Chlorothiazide; Diet Therapy; Diuretics; Ethacrynic Acid; Furosemide; Humans; L | 1969 |
[Clinical observations on the efficacy of a new diuretic: furosemide].
Topics: Adult; Aged; Ascites; Diabetes Insipidus; Diuretics; Furosemide; Heart Failure; Humans; Liver Cirrho | 1965 |
[Furosemide in treatment of the edema syndrome in cirrhotics].
Topics: Ascites; Diuretics; Furosemide; Humans; Liver Cirrhosis | 1965 |
[A new diuretic: Furosemide. Its effect on bilahariasis-cirrhosis with ascites].
Topics: Ascites; Diuretics; Furosemide; Liver Cirrhosis; Schistosomiasis | 1965 |
[The effect of furosemide on the liver function].
Topics: Adult; Aged; Female; Furosemide; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Liver Function | 1966 |
Furosemide therapy in "intractable ascites".
Topics: Adult; Aged; Ascites; Edema; Female; Furosemide; Humans; Liver Cirrhosis; Male; Middle Aged; Water-E | 1966 |
[Furosemide therapy of edematogenic syndromes].
Topics: Diuretics; Edema; Furosemide; Heart Failure; Humans; Liver Cirrhosis | 1966 |
Renal failure with cirrhosis. Observations on the role of diuretics.
Topics: Acute Kidney Injury; Aminohippuric Acids; Ascites; Blood; Blood Volume; Creatine; Diuretics; Ethacry | 1966 |
Evaluation of furosemide. A new diuretic agent in hepatic cirrhosis.
Topics: Adolescent; Adult; Aged; Diuretics; Female; Furosemide; Humans; Liver Cirrhosis; Male; Middle Aged | 1966 |
[Effect of furosemide on liver cirrhosis patients with ascites].
Topics: Ascites; Chlorides; Furosemide; Glomerular Filtration Rate; Humans; Liver Cirrhosis; Natriuresis; Po | 1966 |
[Treatment of ascites in hepatic cirrhosis].
Topics: Acetazolamide; Adult; Aged; Ascites; Benzothiadiazines; Furosemide; Humans; Liver Cirrhosis; Male; M | 1966 |